{
  "meta": {
    "title": "00364_Late_Night_Pyq_Pyt_Obg-7",
    "url": "https://brainandscalpel.vercel.app/00364-late-night-pyq-pyt-obg-7-1d4e81f8.html",
    "scrapedAt": "2025-11-29T17:29:27.702Z"
  },
  "questions": [
    {
      "id": 55332,
      "choices": [
        {
          "id": 220789,
          "text": "<p><span style=\"font-size:12.0pt;\">UPT</span></p>"
        },
        {
          "id": 220790,
          "text": "<p><span style=\"font-size:12.0pt;\">TVS</span></p>"
        },
        {
          "id": 220791,
          "text": "<p><span style=\"font-size:12.0pt;\">Pap smear</span></p>"
        },
        {
          "id": 220792,
          "text": "<p><span style=\"font-size:12.0pt;\">USG abdomen</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 28-year-old P1L1 with irregular bleeding for 1.5 months. What is the next best investigation to do? (FMGE JULY 2024)</span></p>",
      "unique_key": "Q1541357",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585472,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) UPT</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In a 28-year-old woman with irregular bleeding for 1.5 months, the first step is to rule out pregnancy. The initial investigation in this scenario should be a urine pregnancy test (UPT). This is crucial because pregnancy-related complications such as threatened abortion, incomplete abortion, or ectopic pregnancy can present with irregular bleeding. Identifying or excluding pregnancy is the most immediate concern and guides subsequent management.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. TVS (Transvaginal Ultrasound):</strong> This is a valuable tool for assessing pelvic pathology and uterine abnormalities, but it is typically done after confirming the UPT results.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Pap smear:</strong> This test is used for cervical cancer screening and is not the immediate next step in evaluating irregular bleeding when pregnancy needs to be ruled out first.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. USG abdomen:</strong> While an abdominal ultrasound can provide useful information, it is less sensitive than a transvaginal ultrasound for early pregnancy detection and pelvic pathology assessment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In a reproductive-age woman with irregular bleeding, the first investigation should be a urine pregnancy test (UPT) to rule out pregnancy-related causes.</span></p>",
      "correct_choice_id": 220789,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "FMGE",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6023,
      "choices": [
        {
          "id": 24062,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A case of superfetation</span></span></span></p>"
        },
        {
          "id": 24063,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">One infant is atavistic</span></span></span></p>"
        },
        {
          "id": 24064,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A case of superfecundation</span></span></span></p>"
        },
        {
          "id": 24065,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">One infant is suppositious</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A married woman gives birth to twins. The husband doubts he is the father and gets a paternity test done. The test shows that he is the father of one infant but not the other. This is?</span></span><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> (NEET PG 2021)</span></span></span></p>",
      "unique_key": "Q6555221",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585463,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) A case of superfecundation </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Superfecundation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This refers to the fertilization of two ova in the same menstrual cycle by sperm from different acts of intercourse, potentially involving different partners.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This scenario explains how twins can have different fathers, as one ovum could be fertilized by sperm from the husband, and the other by sperm from another man.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Superfetation:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This refers to fertilization of two ova from different menstrual cycles. It is an extremely rare phenomenon and has never been documented in humans, though it is known to occur in some animals.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. One infant is atavistic:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Atavism refers to the appearance of characteristics found in distant ancestors but not observed in recent generations. It does not apply to paternity.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. One infant is suppositious</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Suppositious refers to something that is fraudulently substituted. This term does not explain the situation of having different fathers for twins.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Superfecundation is the fertilization of two ova in the same menstrual cycle by sperm from different partners, explaining how twins can have different fathers.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 2188, Williams Obstetrics 26<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 24064,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47872,
      "choices": [
        {
          "id": 191083,
          "text": "<p><span style=\"font-size:12.0pt;\">Wait for 4 hours and reexamine</span></p>"
        },
        {
          "id": 191084,
          "text": "<p><span style=\"font-size:12.0pt;\">LSCS</span></p>"
        },
        {
          "id": 191085,
          "text": "<p><span style=\"font-size:12.0pt;\">ARM + oxytocin</span></p>"
        },
        {
          "id": 191086,
          "text": "<p><span style=\"font-size:12.0pt;\">Forceps delivery</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A primigravida presented to the labor room at 38 weeks. At 1 pm she is 5 cm dilated. After 4 hours she is 6 cm dilated. What is the next best step?&nbsp;(FMGE JANUARY 2024)</span></p>",
      "unique_key": "Q8086111",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585457,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) ARM + oxytocin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient is experiencing protracted labor, as indicated by a slow progression in cervical dilation (only 1 cm increase in 4 hours). In active labor, the cervix is expected to dilate at a rate of approximately 1 cm per hour. Here, the cervix dilated from 5 cm to 6 cm in 4 hours, indicating a <strong>slow or protracted dilation phase.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Management of Protracted Labor:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Assessment: Evaluate the cause of slow labor, which could be due to issues with <strong>powers (uterine contractions), the passage (pelvis), or the passenger (fetal position or presentation).</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Augmentation of Labor:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">1<sup>st</sup> step: ARM (Artificial Rupture of Membranes): This can help enhance uterine contractions and allow assessment of the amniotic fluid for the presence of meconium, which could indicate fetal distress.</span></li><li><span style=\"font-size:12.0pt;\">2<sup>nd</sup> step: Oxytocin: If contractions remain inadequate after ARM, oxytocin can be administered to strengthen uterine contractions and accelerate labor progress.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Wait for 4 hours and reexamine:&nbsp;</strong>This is not recommended as it allows prolonged labor to continue without intervention, increasing the risk of complications.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. LSCS (Lower Segment Cesarean Section):&nbsp;</strong>While a cesarean section may be necessary if augmentation fails or if there are other indications, it is not the immediate next step without attempting augmentation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Forceps delivery:&nbsp;</strong>Forceps can only be applied when the cervix is fully dilated (10 cm), not at 6 cm.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In a primigravida with protracted labor (slow cervical dilation), the next best step is to perform artificial rupture of membranes (ARM) and administer oxytocin to augment labor and promote adequate uterine contractions.</span></p>",
      "correct_choice_id": 191085,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54786,
      "choices": [
        {
          "id": 218609,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Copper</span></span></p>"
        },
        {
          "id": 218610,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Selenium</span></span></p>"
        },
        {
          "id": 218611,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Zinc</span></span></p>"
        },
        {
          "id": 218612,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Iron</span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreased sexual maturity and hypogonadism in men is seen with deficiency of? (INICET MAY 2024)</span></span></p>",
      "unique_key": "Q7447889",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585460,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Zinc</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Zinc is an essential trace mineral that plays a crucial role in various biological functions, including immune response, protein synthesis, wound healing, DNA synthesis, and cell division. It is also vital for normal growth and development during pregnancy, childhood, and adolescence, as well as for proper reproductive function.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Zinc Deficiency and Sexual Maturity</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Zinc deficiency in men can lead to delayed sexual maturation and hypogonadism. Hypogonadism refers to reduced function of the gonads (testes in men), which can lead to lower testosterone levels and may result in symptoms such as decreased libido, erectile dysfunction, and reduced secondary sexual characteristics. Zinc is important for the synthesis of testosterone and its deficiency can impair reproductive health.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Zinc is essential for male reproductive health, and its deficiency can lead to delayed sexual maturation and hypogonadism.</span></span></span></p>",
      "correct_choice_id": 218611,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5851,
      "choices": [
        {
          "id": 23374,
          "text": "<p><span style=\"font-size:12pt;\">Hair growth</span></p>"
        },
        {
          "id": 23375,
          "text": "<p><span style=\"font-size:12pt;\">Cervical mucus secretion</span></p>"
        },
        {
          "id": 23376,
          "text": "<p><span style=\"font-size:12pt;\">Vaginal cornification</span></p>"
        },
        {
          "id": 23377,
          "text": "<p><span style=\"font-size:12pt;\">Menstruation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Which of the following effects of puberty are not mediated by estrogen?&nbsp;</span><span style=\"font-size:12.0pt;\">(NEET PG 2020)</span></p>",
      "unique_key": "Q7422434",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585502,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Hair growth</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Hair growth (Pubarche)</strong>: The development of axillary and pubic hair is not mediated by estrogen. It occurs due to testosterone in both sexes.</span></li><li><span style=\"font-size:12pt;\"><strong>Estrogen effects</strong>: Estrogen plays a crucial role in various aspects of puberty, including:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">Breast development (thelarche)</span></li><li><span style=\"font-size:12pt;\">Development of internal genitalia</span></li><li><span style=\"font-size:12pt;\">Menarche</span></li><li><span style=\"font-size:12pt;\">Regulation of growth spurt</span></li><li><span style=\"font-size:12pt;\">Epiphyseal closure</span></li><li><span style=\"font-size:12pt;\">Cervical mucus plug formation</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Cervical mucus secretion</strong>: Estrogen is responsible for the secretion of cervical mucus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Vaginal cornification</strong>: Estrogen promotes the cornification (maturation) of the vaginal epithelium.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Menstruation</strong>: Estrogen is critical in regulating the menstrual cycle and the onset of menarche.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Hair growth during puberty is mediated by testosterone, not estrogen. Estrogen is responsible for breast development, internal genitalia development, menarche, growth spurt regulation, epiphyseal closure, and cervical mucus secretion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 531, DC Dutta’s Textbook of Gynecology, 6<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23374,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5850,
      "choices": [
        {
          "id": 23370,
          "text": "<p><span style=\"font-size:12pt;\">Monitor BP and terminate pregnancy if BP rises</span></p>"
        },
        {
          "id": 23371,
          "text": "<p><span style=\"font-size:12pt;\">Immediate Caesarean section</span></p>"
        },
        {
          "id": 23372,
          "text": "<p><span style=\"font-size:12pt;\">Terminate pregnancy at 40 weeks of gestation</span></p>"
        },
        {
          "id": 23373,
          "text": "<p><span style=\"font-size:12pt;\">Induce labor with PGE2 gel</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 35-year-old primigravida who conceived after in-vitro fertilization therapy came for an antenatal checkup at 38 weeks of gestation. Her obstetric history revealed that she was pregnant with DCDA twins. On examination, the first twin was found to be in a breech position and the maternal blood pressure was found to be greater than 140/90 mm Hg on two occasions with grade 1+ proteinuria. What should be done next?&nbsp;</span>(NEET PG 2020)</p>",
      "unique_key": "Q2024766",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585499,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Immediate Caesarean section</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">&nbsp;The patient is a case of&nbsp;</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">Preeclampsia&nbsp;</span></li><li><span style=\"font-size:12pt;\">Twin pregnancy (1<sup>st</sup> twin breech)</span></li></ul></li><li><span style=\"font-size:12pt;\">She is 38 weeks</span></li><li><span style=\"font-size:12pt;\">As she is preeclamptic and has crossed 37 weeks, treatment would be to deliver her immediately.&nbsp;</span></li><li><span style=\"font-size:12pt;\">As the 1<sup>st</sup> twin is non cephalic, the mode of delivery is a cesarean delivery.&nbsp;</span></li><li><span style=\"font-size:12pt;\">Indications of cesarean delivery in multiple pregnancy:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">1<sup>st</sup> twin non cephalic</span></li><li><span style=\"font-size:12pt;\">Monoamniotic monochorionic twins</span></li><li><span style=\"font-size:12pt;\">Conjoined twins</span></li><li><span style=\"font-size:12pt;\">Triplets and above</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Monitor BP and terminate if BP rises</strong>: There is no indication to wait any longer as even in mild pre-eclampsia, delivery is done at 37 weeks. Waiting any longer is simply subjecting both mother and fetus to risks.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Terminate at 40 weeks</strong>: Again, this should not be done as in pre-eclampsia, delivery is planned at 37 weeks (mild) and 34 weeks (severe). This patient is already 38 weeks gestation</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Induce labor with PGE2 gel</strong>: This patient should be delivered by cesarean section as she has twin babies, the 1<sup>st</sup> of twin is breech (non-cephalic). This becomes an indication for an elective LSCS.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In cases of preeclampsia with twin pregnancies where the first twin is in a breech position at 38 weeks, immediate cesarean section is the recommended course of action.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 1778, Williams Obstetrics, 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23371,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6101,
      "choices": [
        {
          "id": 24373,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1, 3</span></span></span></p>"
        },
        {
          "id": 24374,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1, 2</span></span></span></p>"
        },
        {
          "id": 24375,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1, 4</span></span></span></p>"
        },
        {
          "id": 24376,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">3, 4</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A woman presents at 8 weeks of gestation. Which of the following signs can be elicited at this gestation?&nbsp;</span></span></span>(INICET NOV 2022)</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Goodell&#39;s sign</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Osiander&#39;s sign</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Internal ballottement</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lightening</span></span></span></li>\r\n</ol>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>",
      "unique_key": "Q8055607",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585497,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) 1, 2</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Goodell&#39;s sign</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This sign is the softening of the cervix, which can be elicited around the 6th week of gestation.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Osiander&#39;s sign</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This sign refers to the increased pulsation felt through the lateral fornices, which can be detected between 6 to 8 weeks of gestation.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Internal ballottement</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This can be elicited between the 16th and 28th weeks of gestation when the fetus can be felt to move away and return to the fingers upon gentle tap on the cervix.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lightening</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is a sensation of relief of the pressure symptoms due to the engagement of the presenting part, typically felt around 38 weeks of gestation.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. 1, 3</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Internal ballottement cannot be elicited at 8 weeks of gestation as it is typically felt between 16 and 28 weeks.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. 1, 4</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Lightening is not experienced until about 38 weeks of gestation, making this option incorrect.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. 3, 4</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Neither internal ballottement nor lightening can be elicited at 8 weeks of gestation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The signs that can be elicited at 8 weeks of gestation are Goodell&#39;s sign (softening of the cervix) and Osiander&#39;s sign (increased pulsation felt through the lateral fornices).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Signs in early pregnancy are as shown below</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/02/untitled-290.jpg\" style=\"height:580px; width:900px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Dutta&rsquo;s textbook of obstetrics 8<sup>th</sup> edition pg 74</span></strong></span></span></p>",
      "correct_choice_id": 24374,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5995,
      "choices": [
        {
          "id": 23950,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-A, 2-D, 3-C, 4-B</span></span></span></p>"
        },
        {
          "id": 23951,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">﻿﻿﻿1-D, 2-B, 3-C, 4-A</span></span></span></p>"
        },
        {
          "id": 23952,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">﻿﻿﻿1-C, 2-D, 3-B, 4-A</span></span></span></p>"
        },
        {
          "id": 23953,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">﻿﻿﻿1-A, 2-B, 3-D, 4-C</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Match the following disorders causing secondary amenorrhea with their respective lab findings:&nbsp;</span></span>&nbsp;(INICET NOV 2021)</p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/07/screenshot-2024-08-07-172314.png\" style=\"height:196px; width:600px\" /></p>",
      "unique_key": "Q5091772",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585510,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) 1-A, 2-D, 3-C, 4-B</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Secondary amenorrhea is the absence of menses for more than three months in girls or women who previously had regular menstrual cycles or six months in girls or women who had irregular menses.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Premature Ovarian failure: FSH and LH levels will be very high, estrogen levels are low</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Asherman&#39;s syndrome: As the cause in the endometrium, hormonal levels are normal.&nbsp; </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PCOS: Alteration in the LH/FSH ratio</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sheehan&#39;s syndrome/ pituitary apoplexy: Hypogonadotrophic hypogonadism: So FSH and LH are low and so is Estrogen</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">To correctly diagnose the underlying cause of secondary amenorrhea, it is essential to understand and interpret the hormonal profiles associated with different conditions:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Premature Ovarian Failure:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Elevated FSH and LH levels with decreased estradiol indicate ovarian insufficiency.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Asherman Syndrome:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Low levels of FSH, LH, and estradiol suggest an endometrial cause, such as scarring.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PCOS (Polycystic Ovary Syndrome):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Typically characterized by normal FSH, elevated LH, and normal estradiol levels, reflecting an imbalance in gonadotropins.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sheehan Syndrome:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Normal levels of FSH, LH, and estradiol are indicative of pituitary insufficiency, where the pituitary gland fails to stimulate the ovaries.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: William&rsquo;s textbook of gynecology 3<sup>rd</sup> edition Pg 380,</span></strong></span></span></p>",
      "correct_choice_id": 23950,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5924,
      "choices": [
        {
          "id": 23666,
          "text": "<p><span style=\"font-size:12pt;\">Luteinizing hormone</span></p>"
        },
        {
          "id": 23667,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Follicular stimulating hormone</span></p>"
        },
        {
          "id": 23668,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Progesterone</span></p>"
        },
        {
          "id": 23669,
          "text": "<p><span style=\"font-size:12pt;\">Estrogen</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The hormone acting on post ovulatory endometrium is?</span><span style=\"color:black;font-size:12.0pt;\"> (NEET PG 2019)</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/14/untitled-75.jpg\" alt=\"\" width=\"400\" height=\"197\"></span></p>",
      "unique_key": "Q1598869",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585473,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Progesterone</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Post ovulation, there is a significant rise in progesterone levels, which is crucial for the transformation of the endometrium into a secretory phase. This phase is essential for preparing the endometrium for potential implantation of an embryo.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Phases of the Menstrual Cycle:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12pt;\"><strong>Menstruation (0 - 4 days):</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">The shedding of the endometrial lining occurs if there is no pregnancy.</span></li></ul></li><li><span style=\"font-size:12pt;\"><strong>Follicular Phase (10 - 14 days):</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">Follicle-stimulating hormone (FSH) stimulates the growth of ovarian follicles.</span></li><li><span style=\"font-size:12pt;\">Estrogen levels rise, leading to the proliferation of the endometrium.</span></li></ul></li><li><span style=\"font-size:12pt;\"><strong>Ovulation (14th day):</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">Luteinizing hormone (LH) surge leads to the release of an ovum from the dominant follicle.</span></li></ul></li><li><span style=\"font-size:12pt;\"><strong>Luteal Phase (14 - 28 days):</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">The corpus luteum forms and secretes progesterone.</span></li><li><span style=\"font-size:12pt;\">Progesterone causes the endometrium to develop secretory glands and prepare for implantation.</span></li></ul></li></ol><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Luteinizing Hormone:</strong> LH is primarily involved in triggering ovulation and the formation of the corpus luteum.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Follicle-Stimulating Hormone:</strong> FSH is crucial for the growth and maturation of ovarian follicles during the follicular phase.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Estrogen:</strong> Estrogen is significant during the follicular phase for the proliferation of the endometrium but is not the main hormone acting on the post-ovulatory endometrium.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Progesterone is the hormone responsible for preparing the endometrium for implantation during the post-ovulatory phase.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 94, DC Dutta’s Textbook of Gynecology, 6<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23668,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5848,
      "choices": [
        {
          "id": 23362,
          "text": "<p><span style=\"font-size:12pt;\">Fibroid uterus</span></p>"
        },
        {
          "id": 23363,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Endometrial polyp</span></p>"
        },
        {
          "id": 23364,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Endometrial carcinoma</span></p>"
        },
        {
          "id": 23365,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Leiomyosarcoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 60-year-old woman presented with post-menopausal bleeding. Ultrasonography revealed a mass with feeding vessel as shown in the image below. What is the most likely diagnosis?&nbsp;</span>(NEET PG 2020)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/02/picture1.png\" alt=\"\" width=\"300\" height=\"184\"></span></p>",
      "unique_key": "Q2063712",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585498,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Endometrial polyp</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The image is an ultrasound image of the uterus with a thickened endometrium.</span></li><li><span style=\"font-size:12pt;\">The presence of a feeding vessel is very suggestive of an endometrial polyp.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Fibroid uterus</strong>: Fibroid uterus would generally show a different pattern on ultrasound and is characterized by increased vascularity, but it wouldn't typically present with a single feeding vessel like an endometrial polyp.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Endometrial carcinoma</strong>: In endometrial carcinoma, the endometrium would be irregularly thickened with loss of endo-myometrial junction and cystic spaces with increased vascularity throughout.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Leiomyosarcoma</strong>: Leiomyosarcoma, similar to fibroids, would show increased vascularity but with more aggressive features and not a solitary feeding vessel as seen in polyps.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The presence of a single feeding vessel in a mass seen on ultrasonography is highly suggestive of an endometrial polyp.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 460, Williams Gynecology, 3<sup>rd</sup> edition</strong></span></p>",
      "correct_choice_id": 23363,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6004,
      "choices": [
        {
          "id": 23986,
          "text": "<p><span style=\"font-size:12pt;\">Expectant management</span></p>"
        },
        {
          "id": 23987,
          "text": "<p><span style=\"font-size:12pt;\">Single dose methotrexate</span></p>"
        },
        {
          "id": 23988,
          "text": "<p><span style=\"font-size:12pt;\">Salpingectomy</span></p>"
        },
        {
          "id": 23989,
          "text": "<p><span style=\"font-size:12pt;\">Milking of the tube</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old female patient, on treatment for infertility, came with 6 weeks of amenorrhea, abdominal pain, and mild vaginal bleeding. Her beta hCG level was 2800 mlU/mL. On ultrasound, a 3cm mass was seen in the left adnexa. It contained a gestational sac with no fetal cardiac activity. What is the most appropriate management for this patient hCG- Human chorionic gonadotropin?&nbsp;</span>(NEET PG 2021)</p>",
      "unique_key": "Q5931835",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585514,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Single dose methotrexate</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Management of an unruptured ectopic pregnancy can include expectant, medical, or surgical approaches depending on the patient's condition and specific characteristics of the ectopic pregnancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Medical Management (Single Dose Methotrexate):</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Methotrexate is a folic acid antagonist that inhibits DNA synthesis, effectively treating ectopic pregnancies by stopping the growth of the trophoblastic tissue.</span></li><li><span style=\"font-size:12pt;\"><strong>Indications for Methotrexate:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">Patient hemodynamically stable.</span></li><li><span style=\"font-size:12pt;\">No significant symptoms.</span></li><li><span style=\"font-size:12pt;\">Gestational sac size &lt; 3.5 cm.</span></li><li><span style=\"font-size:12pt;\">No visible cardiac activity.</span></li><li><span style=\"font-size:12pt;\">Serum βhCG &lt; 5000 IU/L.</span></li><li><span style=\"font-size:12pt;\">No contraindication to Methotrexate.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In this scenario, the patient has a beta hCG level of 2800 mIU/mL, a 3 cm mass in the left adnexa, and no fetal cardiac activity, making her an appropriate candidate for single-dose methotrexate therapy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Expectant management:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Indications:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">Clinically stable with no pain.</span></li><li><span style=\"font-size:12pt;\">Serum βhCG &lt; 1000 IU/L.</span></li><li><span style=\"font-size:12pt;\">Tubal ectopic &lt; 35 mm with no visible heartbeat.</span></li><li><span style=\"font-size:12pt;\">Ability to return for follow-up.</span></li></ul></li><li><span style=\"font-size:12pt;\"><strong>Reason for not choosing:</strong> The patient's beta hCG level is 2800 mIU/mL and she presents with symptoms, thus expectant management is not suitable.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Salpingectomy:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Indications:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">Significant pain.</span></li><li><span style=\"font-size:12pt;\">Adnexal mass of 35 mm or larger.</span></li><li><span style=\"font-size:12pt;\">Visible fetal heartbeat on ultrasound.</span></li><li><span style=\"font-size:12pt;\">Serum hCG level of 5000 IU/L or more.</span></li></ul></li><li><span style=\"font-size:12pt;\"><strong>Reason for not choosing:</strong> The patient's ectopic pregnancy size and beta hCG levels do not meet the criteria for surgical intervention. She is hemodynamically stable and a good candidate for medical management.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Milking of the tube:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Indications:</strong> Generally not a recommended procedure due to the risk of incomplete removal of trophoblastic tissue and subsequent complications.</span></li><li><span style=\"font-size:12pt;\"><strong>Reason for not choosing:</strong> This option is outdated and not typically recommended for the management of ectopic pregnancies.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In a stable patient with an unruptured ectopic pregnancy, beta hCG levels &lt; 5000 IU/L, gestational sac size &lt; 3.5 cm, and no fetal cardiac activity, single-dose methotrexate is the most appropriate management option.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 378, William’s Obstetrics 25<sup>th</sup> edition, https://www.nice.org.uk/guidance/ng126</strong></span></p>",
      "correct_choice_id": 23987,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55334,
      "choices": [
        {
          "id": 220797,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">3 months</span></span></span></p>"
        },
        {
          "id": 220798,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">6 months</span></span></span></p>"
        },
        {
          "id": 220799,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">9 months</span></span></span></p>"
        },
        {
          "id": 220800,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">12 months</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Exclusive breastfeeding is done for? (FMGE JULY 2024)</span></span></span></p>",
      "unique_key": "Q3573602",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585474,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) 6 months</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Exclusive breastfeeding is recommended for the first 6 months of a baby&#39;s life. During this period, the infant receives only breast milk without any additional food or drink, not even water. Breast milk provides all the essential nutrients, antibodies, and hydration needed for optimal growth and development during these first crucial months. The World Health Organization (WHO) and other health authorities strongly advocate for exclusive breastfeeding for 6 months due to its significant health benefits for both the baby and the mother.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Exclusive breastfeeding should be practiced for the first 6 months of a baby&#39;s life to ensure they receive optimal nutrition and immune support.</span></span></span></p>",
      "correct_choice_id": 220798,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55338,
      "choices": [
        {
          "id": 220813,
          "text": "<p><span style=\"font-size:12.0pt;\">&gt;28 days</span></p>"
        },
        {
          "id": 220814,
          "text": "<p><span style=\"font-size:12.0pt;\">&gt;30 days</span></p>"
        },
        {
          "id": 220815,
          "text": "<p><span style=\"font-size:12.0pt;\">&nbsp;&gt;35 days</span></p>"
        },
        {
          "id": 220816,
          "text": "<p><span style=\"font-size:12.0pt;\">&nbsp;&gt;38 days</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which menstrual cycle length is abnormal? (FMGE JULY 2024)</span></p>",
      "unique_key": "Q2066218",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585478,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>D) &gt;38 days</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">According to the latest FIGO (International Federation of Gynecology and Obstetrics) classification, the <strong>normal menstrual cycle length ranges from 24 to 38 days.</strong> A cycle length exceeding 38 days is considered abnormal and is classified as infrequent or delayed menstruation. Previously, the normal range was considered 21 to 35 days, but this has been updated to reflect a broader range of normal cycle lengths.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Menstrual cycle abnormalities are categorized based on the frequency of the cycles:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Frequent cycles:</strong> Less than 24 days</span></li><li><span style=\"font-size:12.0pt;\"><strong>Normal cycles:</strong> 24 to 38 days</span></li><li><span style=\"font-size:12.0pt;\"><strong>Infrequent cycles:</strong> More than 38 days</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Understanding these classifications helps in diagnosing and managing menstrual disorders effectively.</span></p>",
      "correct_choice_id": 220816,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5980,
      "choices": [
        {
          "id": 23890,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">G2P2</span></span></span></p>"
        },
        {
          "id": 23891,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">G3P2</span></span></span></p>"
        },
        {
          "id": 23892,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">G2P1</span></span></span></p>"
        },
        {
          "id": 23893,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">G3P1</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 28-year-old pregnant woman came for a routine antenatal check-up in her second trimester. Four years back, she delivered 2 healthy full-term twins. What would her obstetric score be?</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;</span></span>(NEET PG 2021)</p>",
      "unique_key": "Q1186835",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585501,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) G2P1 </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2 formulas</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1. G __ P __ L __ A ___</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gravida (G): The number of times a woman has conceived including the present pregnancy irrespective of the gestational age or the outcome.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Para (P): The number of times a pregnancy has crossed the period of viability (taken as 28 weeks for all practical purposes) EXCLUDING the present pregnancy.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Living (L): The total number of living children the woman has. </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Abortion (A): The total number of times the pregnancy has resulted in an abortion/ pregnancy has not crossed the period of viability. </span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IMPORTANT: A Twin pregnancy which has crossed the period of viability is considered as Para 1 NOT Para 2. If it results in 2 living children, it will be Live 2. </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2. P A-B-C-D (A: term; B: preterm; C: abortions; D: Living)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is another way to write the formula. </span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. G2P2:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Incorrect because the woman has had only one previous pregnancy that reached viability, not two.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. G3P2:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Incorrect because this implies she has had three pregnancies and two have reached viability, which is not the case.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. G3P1:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Incorrect because this implies three pregnancies, but she is currently in her second pregnancy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A twin pregnancy that has crossed the period of viability is considered as Para 1, not Para 2. If it results in two living children, it will be Live 2.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 469, Williams Obstetrics 26<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 23892,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5715,
      "choices": [
        {
          "id": 22832,
          "text": "<p><span style=\"font-size:12pt;\">Reassure and advice regular follow up once in 6 months</span></p>"
        },
        {
          "id": 22833,
          "text": "<p><span style=\"font-size:12pt;\">Confirm USG findings by ordering CT scan</span></p>"
        },
        {
          "id": 22834,
          "text": "<p><span style=\"font-size:12pt;\">Do an exploratory laparoscopy to visualize the nature of cyst</span></p>"
        },
        {
          "id": 22835,
          "text": "<p><span style=\"font-size:12pt;\">Do CA-125 levels, if normal advise regular check up</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 62-year-old female with history of ovarian carcinoma in the mother achieved menopause with smooth transition. She is on hormone replacement therapy. She developed abdominal pain. On examination, a right adnexal mass was palpable and non-tender. On ultrasound, a 3 X 3 cm smooth cyst in her ovary was noted. What is the next best step?&nbsp;(INICET MAY 2017)</span></p>",
      "unique_key": "Q7773638",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585496,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Do CA-125 levels, if normal advise regular check up</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The next best step in managing a postmenopausal woman with a small (3 x 3 cm) smooth ovarian cyst is to measure CA-125 levels. CA-125 is a tumor marker used to assess the risk of ovarian cancer, especially in postmenopausal women. Given the benign characteristics of the cyst on ultrasound and the small size, the initial step is to evaluate CA-125 levels:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>CA-125 Levels:</strong> If the CA-125 levels are normal (less than 35), the patient can be advised to have regular follow-ups.</span></li><li><span style=\"font-size:12pt;\"><strong>Regular Follow-ups:</strong> If CA-125 levels are normal, a transvaginal ultrasound (TVS) should be repeated in 6-12 weeks to monitor the cyst. If the cyst persists but remains benign, yearly TVS is recommended.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Reassure and advise regular follow-up once in 6 months:</strong> While reassurance is part of the management, initial evaluation with CA-125 is necessary to rule out malignancy before deciding on the follow-up schedule.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Confirm USG findings by ordering a CT scan:</strong> A CT scan is not the first-line investigation for a simple cyst with benign features. Initial evaluation with CA-125 is more appropriate.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Do an exploratory laparoscopy to visualize the nature of the cyst:</strong> This is invasive and not indicated for a small, benign-appearing cyst without other concerning features.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/18/screenshot-2023-11-18-104932.jpg\" alt=\"\" width=\"1000\" height=\"873\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Simple cysts in the post-menopausal age grp:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">≤ 1cm: Considered normal</span></li><li><span style=\"font-size:12pt;\">≤ 5 cm: Ca125; if normal, repeat in 6-12 weeks</span></li><li><span style=\"font-size:12pt;\">&gt; 6 cm: Surgical evaluation</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 217, Williams Gynecology 3<sup>rd</sup> edition</strong></span></p>",
      "correct_choice_id": 22835,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55333,
      "choices": [
        {
          "id": 220793,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Iron</span></span></span></p>"
        },
        {
          "id": 220794,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Calcium</span></span></span></p>"
        },
        {
          "id": 220795,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Folic acid</span></span></span></p>"
        },
        {
          "id": 220796,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Vitamin B12</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">What is given to prevent neural tube defects? (FMGE JULY 2024)</span></span></span></p>",
      "unique_key": "Q8542088",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585475,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>C) Folic acid</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Folic acid supplementation is essential for the prevention of neural tube defects (NTDs) in the developing fetus. Neural tube defects are severe birth defects of the brain and spine, such as spina bifida and anencephaly, that occur when the neural tube does not close completely. Folic acid, a B-vitamin, significantly reduces the risk of these defects when taken in adequate amounts before conception and during early pregnancy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It is recommended that women start taking folic acid atleast three months before conception and continue through the first three months of pregnancy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">For women at low risk, the recommended dose is 0.4 to 0.5 mg per day. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">For those at high risk, including women with a previous pregnancy affected by NTDs, known folate deficiency, overt diabetes mellitus, or those on anti-epileptic drugs, the recommended dose is 4 to 5 mg per day.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><strong>Option A.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Iron:</strong> This option is incorrect as iron supplementation is used primarily to prevent and treat anemia in pregnancy, not to prevent neural tube defects.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><strong>Option B.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Calcium:</strong> This is incorrect because calcium is important for the development of the fetal skeletal system and for maternal bone health, but it does not prevent neural tube defects.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><strong>Option D.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Vitamin B12:</strong> This option is incorrect as vitamin B12, while important for overall neurological health, is not the primary supplement used to prevent neural tube defects. However, B12 works synergistically with folic acid, and deficiency in B12 can contribute to NTDs.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Folic acid supplementation before conception and during early pregnancy is crucial to prevent neural tube defects in the developing fetus.</span></span></span></p>",
      "correct_choice_id": 220795,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6001,
      "choices": [
        {
          "id": 23974,
          "text": "<p><span style=\"font-size:12pt;\">Discontinue the packet and start an alternate method of contraception</span></p>"
        },
        {
          "id": 23975,
          "text": "<p><span style=\"font-size:12pt;\">Take 4 tablets the next day, continue the remaining packet, use additional contraception (condom) and give Emergency Pill if h/o intercourse in the last 72 h</span></p>"
        },
        {
          "id": 23976,
          "text": "<p><span style=\"font-size:12pt;\">Take the next pill as soon as possible, continue the remaining packet, use additional contraception (condom) and give Emergency Pill if h/o intercourse in the last 72 h</span></p>"
        },
        {
          "id": 23977,
          "text": "<p><span style=\"font-size:12pt;\">Take the next pill as soon as possible and continue the remaining tablets</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Reema Devi, A 28y newly married woman presents to your sub center for contraceptive advice. She is started on Oral Contraceptive Pills. She presents after 2 weeks with a history of missing 4 tablets on different days in the first 2 weeks of the cycle. What will you advise her? (NEET PG 2021)</span></p>",
      "unique_key": "Q8434890",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585513,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Take the next pill as soon as possible, continue the remaining packet, use additional contraception (condom) and give Emergency Pill if h/o intercourse in the last 72 h</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_WEpAJ8N.png\" width=\"929\" height=\"519\"></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Missing a pill increases the risk of pregnancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Management of Missed Pill</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/15/14.jpg\" alt=\"\" width=\"1000\" height=\"363\"></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">** In this question, she has missed 4 pills in the 1<sup>st</sup> 2 weeks Hence, she should take the last missed pill, use additional contraception, use emergency contraception, and continue the remaining pack</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Discontinue the packet and start an alternate method of contraception:</strong> Discontinuing the packet is not advised as it can lead to hormonal imbalance and irregular cycles. An alternate method of contraception can be considered only if the patient prefers to switch, but it is not an immediate solution for the current cycle's missed pills.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Take 4 tablets the next day, continue the remaining packet, use additional contraception (condom) and give emergency pill if h/o intercourse in the last 72 hours:</strong> Taking 4 tablets the next day is excessive and unnecessary. The correct approach is to take the last missed pill and continue as usual.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Take the next pill as soon as possible and continue the remaining tablets:&nbsp;</strong>This option neglects the need for additional contraception and emergency contraception, which are crucial to prevent pregnancy in this scenario.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">If a woman misses multiple oral contraceptive pills, she should take the last missed pill as soon as possible, continue the remaining packet, use additional contraception, and consider emergency contraception if she had intercourse in the last 72 hours.</span></p>",
      "correct_choice_id": 23976,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5707,
      "choices": [
        {
          "id": 22800,
          "text": "<p><span style=\"font-size:12.0pt;\">Pelvic inflammatory disease</span></p>"
        },
        {
          "id": 22801,
          "text": "<p><span style=\"font-size:12.0pt;\">Ectopic pregnancy</span></p>"
        },
        {
          "id": 22802,
          "text": "<p><span style=\"font-size:12.0pt;\">Menstrual irregularities</span></p>"
        },
        {
          "id": 22803,
          "text": "<p><span style=\"font-size:12.0pt;\">Endometriosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">When is dilatation and curettage contraindicated?</span> <span style=\"font-size:12.0pt;\">(NEET PG 2018)</span></p>",
      "unique_key": "Q2858799",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585492,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Pelvic inflammatory disease</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Pelvic inflammatory disease (PID) includes endometritis, salpingitis, oophoritis, and parametritis. Any interventions like dilatation and curettage (D&amp;C) are contraindicated in active PID due to the risk of exacerbating the infection and causing further complications.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Ectopic pregnancy</strong>: D&amp;C is not contraindicated in ectopic pregnancy; however, it is not typically performed in its management as it does not provide any benefit for this condition.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Menstrual irregularities</strong>: D&amp;C can be performed to obtain an endometrial biopsy in peri-menopausal women with abnormal uterine bleeding (AUB) if there are no other identifiable causes and if endometrial hyperplasia or malignancy is suspected.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Endometriosis</strong>: D&amp;C is not usually performed solely for endometriosis unless there is an associated AUB that needs to be evaluated or treated.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Dilatation and curettage (D&amp;C) is contraindicated in active pelvic inflammatory disease (PID) due to the risk of spreading the infection</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Page 168, DC Dutta’s Textbook of Gynecology, 6<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 22800,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "OlderNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5996,
      "choices": [
        {
          "id": 23954,
          "text": "<p><span style=\"font-size:12pt;\">1, 2, 5, 6</span></p>"
        },
        {
          "id": 23955,
          "text": "<p><span style=\"font-size:12pt;\">1, 2, 3, 5</span></p>"
        },
        {
          "id": 23956,
          "text": "<p><span style=\"font-size:12pt;\">1, 2, 4, 6</span></p>"
        },
        {
          "id": 23957,
          "text": "<p><span style=\"font-size:12pt;\">1, 2, 3, 6</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Which of the following instruments are used in the caesarean section?&nbsp;</span>&nbsp;(INICET NOV 2021)</p><p>&nbsp;</p><ol><li><span style=\"font-size:12pt;\">Bard-Parker blade</span></li><li><span style=\"font-size:12pt;\">Doyen's retractor</span></li><li><span style=\"font-size:12pt;\">Cusco's speculum</span></li><li><span style=\"font-size:12pt;\">Allis forceps</span></li><li><span style=\"font-size:12pt;\">Shirodkar's uterine clamp</span></li><li><span style=\"font-size:12pt;\">Green Armytage forceps</span></li></ol>",
      "unique_key": "Q2733850",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585511,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) 1, 2, 4, 6</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Instruments used in a cesarean section</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">BP handle</span></li><li><span style=\"font-size:12pt;\">Allis forceps</span></li><li><span style=\"font-size:12pt;\">Artery forceps</span></li><li><span style=\"font-size:12pt;\">Doyen retractor</span></li><li><span style=\"font-size:12pt;\">Green Armitage forceps</span></li><li><span style=\"font-size:12pt;\">Metzenbaum scissors</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Among the options</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Cusco’s speculum has no role in LSCA It is a vaginal self-retaining speculum with two blades</span></li><li><span style=\"font-size:12pt;\">Shirodkar’s uterine clamp is used in gynecological procedures to hold the uterus.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Identify that Bard-Parker blade, Doyen's retractor, Allis forceps, and Green Armytage forceps are essential instruments used in a cesarean section, while Cusco's speculum and Shirodkar's uterine clamp are not used in this procedure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Dutta’s Textbook of Obstetrics 8<sup>th</sup> edition Page no 756</strong></span></p>",
      "correct_choice_id": 23956,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "InstrumentsBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 21800,
      "choices": [
        {
          "id": 87164,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\">Prolonged second stage</span></span></span></p>"
        },
        {
          "id": 87165,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\">Maternal Exhaustion</span></span></span></p>"
        },
        {
          "id": 87166,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\">Fetal Distress</span></span></span></p>"
        },
        {
          "id": 87167,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\">Premature baby</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following situations is not managed by using Ventouse for a delivery? (FMGE JAN 2023)</span></span></p>",
      "unique_key": "Q2650389",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585476,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Premature baby</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ventouse assisted delivery can cause Intracranial hemorrhage in a preterm fetus</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/19/untitled-1042.jpg\" style=\"height:440px; width:1000px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/19/untitled-1043.jpg\" style=\"height:434px; width:500px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/19/untitled-1044.jpg\" style=\"height:272px; width:500px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Prolonged second stage:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Ventouse is commonly indicated for prolonged second stage of labor to assist in the delivery process.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Maternal Exhaustion:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Maternal exhaustion is another indication for operative vaginal delivery using either forceps or ventouse to expedite delivery and reduce maternal strain.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Fetal Distress:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Fetal distress is an indication for immediate delivery, and ventouse can be used to quickly assist in the delivery when immediate intervention is required.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ventouse-assisted delivery is contraindicated in premature babies due to the risk of intracranial hemorrhage.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: D.C. Dutta&rsquo;s Textbook of Obstetrics 8<sup>th</sup> Edition page 652,661</span></strong></span></span></p>",
      "correct_choice_id": 87167,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE",
        "InstrumentsBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5952,
      "choices": [
        {
          "id": 23778,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Mullerian agenesis</span></span></span></p>"
        },
        {
          "id": 23779,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Gonadal dysgenesis</span></span></span></p>"
        },
        {
          "id": 23780,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Turner syndrome</span></span></span></p>"
        },
        {
          "id": 23781,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Testicular feminization syndrome</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 17-year-old girl was brought by her mother to the outpatient department with primary amenorrhea. She had normal breast development and pubic hair. On examination, the vagina was blind-ending and the uterus was not palpable. What is the most probable diagnosis?&nbsp;</span></span>(INICET MAY 2021)</p>",
      "unique_key": "Q9331622",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585488,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Mullerian agenesis</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The given clinical scenario of a girl with primary amenorrhea, normal breasts, and pubic hair, with a blind-ending vagina and uterus not palpable, is suggestive of Mullerian agenesis.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Absent uterus and vagina in a person with female genotype and phenotype are features of Mullerian agenesis, also known as Mayer-Rokitansky-Kuster-Hauser syndrome.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">As ovaries are present, normal secondary sexual characters will develop</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Gonadal dysgenesis</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Gonadal dysgenesis patients present with primary amenorrhoea, absence of secondary sex characters poorly developed breasts</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Turner syndrome</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: In Turner syndrome, short stature with poor development of secondary sexual characters and short stature will be seen. It has a karyotype of 45 XO. The ovaries are streak ovaries</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Testicular feminization syndrome</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Testicular feminization syndrome also known as androgen insensitivity syndrome has a karyotype of 46XY. Secondary sexual characters like the development of axillary hair and pubic hair are absent in these females. However, breast development is adequate due to the conversion of androgen into estrogen during puberty.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"><br />\r\n<span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Mullerian agenesis is characterized by the absence of the uterus and the upper part of the vagina, with normal ovarian function leading to normal breast and pubic hair development.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Page no 450, DC Dutta&rsquo;s Textbook of Gynecology 6<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 23778,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5729,
      "choices": [
        {
          "id": 22888,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Colposcopy directed biopsy</span></span></span></span></p>"
        },
        {
          "id": 22889,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cone biopsy</span></span></span></span></p>"
        },
        {
          "id": 22890,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Repeat pap smear</span></span></span></span></p>"
        },
        {
          "id": 22891,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hysterectomy</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old lady complains of post-coital bleeding. She has a positive pap smear. What is the next line of management?</span></span> <span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(NEET PG 2018)</span></span></p>",
      "unique_key": "Q2923137",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585506,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Colposcopy directed biopsy </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A positive pap smear indicates the presence of some cytological abnormality (such as epithelial or glandular cell abnormalities). The next appropriate step is to perform a colposcopy and directed biopsy. Colposcopy provides a magnified view of the cervix, allowing for the identification and biopsy of abnormal areas. During the colposcopy, scoring systems like Ried&rsquo;s index or Swede&rsquo;s score are used to evaluate the severity of the pathology, and cervical biopsy samples are taken from acetowhite areas identified during the procedure.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Cone biopsy (Conization):</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Conization is typically reserved for situations where there is:</span></span></span></span>\r\n\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Unsatisfactory colposcopic findings (where the entire lesion cannot be visualized).</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inconsistent findings between colposcopy, cytology, and directed biopsy.</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Positive endocervical curettage.</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">When biopsy cannot rule out invasive cancer from carcinoma in situ (CIS) or microinvasion.</span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Repeat pap smear:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is not preferred in this scenario as the exact abnormality on the pap smear is not specified. In cases of low-grade squamous intra-epithelial lesion (LSIL) with negative HPV, a repeat pap smear with HPV testing may be advised, but this is not applicable here.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Hysterectomy:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hysterectomy is never indicated solely for an abnormal pap smear. It is considered only if the colposcopic-directed biopsy shows:</span></span></span></span>\r\n\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cervical intraepithelial neoplasia (CIN) associated with other gynecologic problems such as prolapse, fibroids, pelvic inflammatory disease, or endometriosis.</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Persistent dyskaryotic smear despite treatment.</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">High-grade CIN in elderly women.</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Patients with poor compliance for follow-up.</span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Following a positive pap smear indicating abnormal cytology, the next step is to perform a colposcopy and directed biopsy to further evaluate and manage the cervical pathology.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 329, Dc Duttas Textbook of Gynecology 6<sup>th</sup> edition</span></span></strong></span></span></p>",
      "correct_choice_id": 22888,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5712,
      "choices": [
        {
          "id": 22820,
          "text": "<p><span style=\"font-size:12pt;\">Conization</span></p>"
        },
        {
          "id": 22821,
          "text": "<p><span style=\"font-size:12pt;\">Hysterectomy</span></p>"
        },
        {
          "id": 22822,
          "text": "<p><span style=\"font-size:12pt;\">Repeat Colposcopy and biopsy after 6 months</span></p>"
        },
        {
          "id": 22823,
          "text": "<p><span style=\"font-size:12pt;\">HPV DNA testing</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old female came for routine PAP smear testing. The report came as HSIL. On colposcopy and biopsy, it was confirmed to be carcinoma in situ. What is the next step?&nbsp;(INICET MAY 2017)</span></p>",
      "unique_key": "Q5274902",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585494,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Conization</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Carcinoma in situ (CIS) of the cervix is classified as Stage 0 cancer. In a young woman with stage 0 cervical cancer, the management of choice is conization. Conization involves the removal of a cone-shaped section of the cervix, including the transformation zone and part of the endocervix. This procedure serves both diagnostic and therapeutic purposes:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Diagnostic:</strong> Conization provides a tissue specimen for histopathological examination, which is more definitive compared to a cytological specimen obtained from a Pap smear.</span></li><li><span style=\"font-size:12pt;\"><strong>Therapeutic:</strong> If the histopathology shows clear margins, conization can be curative for carcinoma in situ.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Hysterectomy:</strong> This is a more radical treatment and is generally reserved for cases where there is invasive cancer or other indications. It is not the first-line treatment for CIS in a young woman.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Repeat colposcopy and biopsy after 6 months:</strong> In the case of confirmed carcinoma in situ, conization is preferred. There is no need of repeat colpobiopsy&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. HPV DNA testing:</strong> This test is used for screening and risk assessment but is not a treatment for confirmed carcinoma in situ.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Conization, which involves the removal of a cone-shaped section of the cervix including the transformation zone and part of the endocervix, is the management of choice for carcinoma in situ in young women. It is both diagnostic and therapeutic if histopathology shows clear margins.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/18/picture2_ByHlD4H.jpg\" alt=\"\" width=\"500\" height=\"354\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 992, Williams Gynecology 3<sup>rd</sup> edition</strong></span></p>",
      "correct_choice_id": 22820,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 56959,
      "choices": [
        {
          "id": 227225,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LBC + HPV + cervical biopsy</span></span></p>"
        },
        {
          "id": 227226,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pap smear + HCV</span></span></p>"
        },
        {
          "id": 227227,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pap smear + HBV</span></span></p>"
        },
        {
          "id": 227228,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">VDRL + HBV</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old woman with a history of cervical erosion and spotting since 2 months. What is the next best step?&nbsp;(NEET PG 2024)</span></span></p>",
      "unique_key": "Q3074186",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585516,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A)&nbsp; LBC + HPV + cervical biopsy</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient is a 45-year-old woman presenting with cervical erosion and spotting, which raises a concern for potential cervical cancer. In such cases, the next best step involves a comprehensive approach to screen for cervical cancer:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Liquid-based cytology (LBC):</span></strong><span style=\"font-size:12.0pt\"> This test is used to detect abnormal cells in the cervix.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">HPV testing:</span></strong><span style=\"font-size:12.0pt\"> This helps identify high-risk human papillomavirus strains that are associated with cervical cancer.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Cervical biopsy:</span></strong><span style=\"font-size:12.0pt\"> If any abnormalities are found on cytology or HPV testing, a cervical biopsy can confirm the diagnosis.</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Performing all three tests together provides a thorough evaluation, as cervical cancer screening is essential in women presenting with these symptoms.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Pap smear + HCV:</span></strong><span style=\"font-size:12.0pt\"> While a Pap smear is appropriate for screening, HCV (Hepatitis C Virus) testing is unrelated to the current presentation of cervical symptoms.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Pap smear + HBV:</span></strong><span style=\"font-size:12.0pt\"> Similar to option B, the Pap smear is correct, but testing for HBV (Hepatitis B Virus) does not address the concern for cervical cancer.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. VDRL + HBV:</span></strong><span style=\"font-size:12.0pt\"> VDRL is used for syphilis screening and is not relevant to cervical erosion and spotting, nor is HBV testing in this context.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">For a patient with cervical erosion and spotting, the best approach is to screen for cervical cancer with LBC, HPV testing, and a cervical biopsy if indicated.</span></span></span></p>",
      "correct_choice_id": 227225,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "InvestigationBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5931,
      "choices": [
        {
          "id": 23694,
          "text": "<p><span style=\"font-size:12pt;\">46 XX</span></p>"
        },
        {
          "id": 23695,
          "text": "<p><span style=\"font-size:12pt;\">45 XY</span></p>"
        },
        {
          "id": 23696,
          "text": "<p><span style=\"font-size:12pt;\">69 XY</span></p>"
        },
        {
          "id": 23697,
          "text": "<p><span style=\"font-size:12pt;\">69 XXY</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">What is the chromosome number of a partial hydatidiform mole?</span><span style=\"font-size:12.0pt;\">&nbsp;(</span>NEET PG 2019)</p>",
      "unique_key": "Q8236691",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585480,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) 69 XXY</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Partial hydatidiform moles are characterized by being triploid, meaning they have three sets of chromosomes. The chromosome number for a partial mole is typically 69, which can be either 69XXX or 69XXY.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Formation of Partial Mole:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">Partial moles occur when two sperm fertilize a single ovum (egg). This process is called diandry.</span></li><li><span style=\"font-size:12pt;\">As a result, both maternal and paternal genetic components are present in a partial mole.</span></li><li><span style=\"font-size:12pt;\">The most common karyotypes for partial moles are 69XXX and 69XXY.</span></li></ul></li><li><span style=\"font-size:12pt;\"><strong>Complete Mole Characteristics:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">Complete moles are diploid, meaning they have two sets of chromosomes.</span></li><li><span style=\"font-size:12pt;\">They form either by:</span><ul style=\"list-style-type:square;\"><li><span style=\"font-size:12pt;\">One sperm fertilizing an empty or inactivated ovum and then undergoing duplication, a process known as androgenesis, or</span></li><li><span style=\"font-size:12pt;\">Two sperm (dispermy) fertilizing an empty or inactivated ovum.</span></li></ul></li><li><span style=\"font-size:12pt;\">The chromosome number for complete moles is typically 46XX or 46XY.</span></li><li><span style=\"font-size:12pt;\">Only the paternal genetic component is present, with no maternal contribution.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. 46 XX</strong>: This karyotype is typical for a complete mole, not a partial mole.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. 45 XY</strong>: This karyotype is not typical for either complete or partial moles.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. 69 XY</strong>: This option is incorrect as partial moles can be 69XY, but 69XXY is more specific and typical.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Partial hydatidiform moles are triploid, typically having a chromosome number of 69, which can be 69XXX or 69XXY.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 616, Williams Obstetrics 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23697,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 21809,
      "choices": [
        {
          "id": 87200,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stria Gravidarum</span></span></span></p>"
        },
        {
          "id": 87201,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Linea Alba</span></span></span></p>"
        },
        {
          "id": 87202,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Linea Nigra</span></span></span></p>"
        },
        {
          "id": 87203,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stria albicans</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Identify the finding shown in image given below:&nbsp;</span></span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\">(FMGE JANUARY 2023)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/19/untitled-1046_Xio1rZb.jpg\" style=\"height:265px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q9228057",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585482,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Linea Nigra</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A hyperpigmented line from xiphisternum to pubic symphysis is Linea Nigra.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><strong><span style=\"font-family:Calibri,sans-serif\">Option A.</span><span style=\"font-family:Times New Roman, serif\">&nbsp;</span></strong><strong style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stria gravidarum</span></strong><span style=\"font-family:Calibri,sans-serif\">: Stria gravidarum is a reddish stria of present pregnancy.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Linea Alba</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: The midline of the anterior abdominal wall skin. It takes on dark brown-black pigmentation to form the linea nigra.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><strong><span style=\"font-family:Calibri,sans-serif\">&nbsp;Option D.</span><span style=\"font-family:Times New Roman, serif\">&nbsp;</span></strong><strong style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stria albicans</span></strong><span style=\"font-family:Calibri,sans-serif\">: Stria albicans is a silvery stria of previous pregnancies.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A hyperpigmented line from xiphisternum to pubic symphysis is Linea Nigra.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 79, DC Dutta&rsquo;s Textbook of Obstetrics 8<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 87202,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6111,
      "choices": [
        {
          "id": 24413,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Review USG after 2 weeks</span></span></span></p>"
        },
        {
          "id": 24414,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Schedule elective LSCS at 37 weeks</span></span></span></p>"
        },
        {
          "id": 24415,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">ECV at 36 weeks</span></span></span></p>"
        },
        {
          "id": 24416,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Await spontaneous labor and then do an internal podalic version</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 34 year G2P1 presents at 35 weeks. She has no complaints and is appreciating fetal movements well. She had a previous classical cesarean at 25 weeks for eclampsia and severe FGR. She is currently on low dose aspirin and prenatal vitamins. On examination, the uterus is SFH is 38 cm and FHR is 140 bpm. An ultrasound reveals a single live fetus in breech presentation, placenta posterior and amniotic fluid normal. The patient desires a vaginal delivery. What is the best management?&nbsp;</span></span></span>(NEET PG 2022)</p>",
      "unique_key": "Q8187735",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585504,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Schedule elective LSCS at 37 weeks</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Schedule elective LSCS at 37 weeks:</span></strong></span></span>\r\n\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient has a history of a classical cesarean section, which is an absolute contraindication to vaginal delivery due to the high risk of uterine rupture.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A classical cesarean section involves a vertical incision on the upper part of the uterus, which does not heal as strongly as the lower segment horizontal incision, leading to a higher risk of rupture during labor.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Given the breech presentation and the patient&#39;s obstetric history, an elective cesarean section at 37 weeks is the safest option to prevent complications.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Review USG after 2 weeks:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This option does not address the critical issue of the patient&#39;s previous classical cesarean section, which necessitates planning for a repeat cesarean delivery.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. ECV at 36 weeks:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">External Cephalic Version (ECV) is contraindicated in patients with a previous classical cesarean section due to the increased risk of uterine rupture.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Await spontaneous labor and then do an internal podalic version:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Awaiting spontaneous labor is not advisable due to the increased risk of uterine rupture with a classical cesarean scar. Additionally, internal podalic version is not a recommended procedure in this context.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A classical cesarean section is an absolute contraindication to a vaginal delivery due to the high risk of uterine rupture; hence, an elective cesarean section should be scheduled at 37 weeks.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 1439, William Obstetrics, 26<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 24414,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6028,
      "choices": [
        {
          "id": 24082,
          "text": "<p><span style=\"font-size:12pt;\">It is best tested in the fasting state on day 2 of menstrual cycle</span></p>"
        },
        {
          "id": 24083,
          "text": "<p><span style=\"font-size:12pt;\">Glycoprotein from granulosa cell of early antral follicle</span></p>"
        },
        {
          "id": 24084,
          "text": "<p><span style=\"font-size:12pt;\">Correlates with pregnancy rate of IVF cycles</span></p>"
        },
        {
          "id": 24085,
          "text": "<p><span style=\"font-size:12pt;\">It decreases sensitivity of the pre-antral follicles to FSH</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">All of the following statements about anti-Mullerian hormones are true, except:&nbsp;</span>(INICET MAY 2022)</p>",
      "unique_key": "Q1959793",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585465,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) It is best tested in the fasting state on day 2 of menstrual cycle</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Anti-Mullerian Hormone (AMH) is a glycoprotein secreted by the Sertoli cells in males and the granulosa cells of early antral follicles in females. It serves as a marker of ovarian reserve and is crucial in assessing fertility potential. Here are the reasons why option A is incorrect:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>AMH Testing:</strong> Unlike some other hormones, AMH does not require fasting and can be tested at any time during the menstrual cycle. The timing of testing AMH is not restricted to day 2 of the menstrual cycle as with some other reproductive hormone assessments.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Glycoprotein from granulosa cell of early antral follicle</strong>: This is a true statement. AMH is indeed a glycoprotein produced by the granulosa cells of early antral follicles in the ovaries.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Correlates with pregnancy rate of IVF cycles</strong>: This is also true. AMH levels correlate with ovarian reserve and can give an indication of the likelihood of a successful IVF cycle. Higher levels generally suggest a better response to ovarian stimulation and thus potentially higher pregnancy rates.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. It decreases sensitivity of the pre-antral follicles to FSH</strong>: This statement is correct. AMH reduces the sensitivity of pre-antral and small antral follicles to Follicle-Stimulating Hormone (FSH), which is a mechanism to regulate follicle recruitment and maturation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Anti-Mullerian Hormone (AMH) does not need to be tested in the fasting state or specifically on day 2 of the menstrual cycle.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 76, DC Dutta’s Textbook of Gynecology 6<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 24082,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5810,
      "choices": [
        {
          "id": 23210,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">At the onset of labor</span></span></span></p>"
        },
        {
          "id": 23211,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">34 weeks</span></span></span></p>"
        },
        {
          "id": 23212,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">36 weeks</span></span></span></p>"
        },
        {
          "id": 23213,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">40 weeks</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A pregnant woman with cardiac disease is on warfarin therapy. When will the final switch to heparin be advised?&nbsp;</span></span>(INICET MAY 2018)</p>",
      "unique_key": "Q8889904",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585484,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) 36 weeks</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The management of anticoagulation in pregnant women with cardiac disease involves switching from warfarin to heparin at specific times to minimize the risk of complications to the fetus and to prepare for delivery.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Switch to Heparin at 36 Weeks:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> According to guidelines from the American College of Chest Physicians, pregnant women on warfarin therapy should switch to heparin at 36 weeks of gestation. This is done to reduce the risk of bleeding complications during labor and delivery.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Guidelines Summary:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Early Pregnancy (up to 12 weeks):</span></strong></span></span>\r\n\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Discontinue warfarin as soon as pregnancy is diagnosed, especially if the warfarin dose is &gt;5mg/day, due to the risk of warfarin embryopathy.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Replace with heparin (5,000 units twice daily subcutaneously) or low molecular weight heparin (LMWH).</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">After 12 Weeks to 36 Weeks:</span></strong></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Warfarin can be resumed after the 12th week and continued up to 36 weeks.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">At 36 Weeks:</span></strong></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Switch from warfarin to heparin (either unfractionated or LMWH).</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Just Before Delivery:</span></strong></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Discontinue heparin just before delivery.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Postpartum:</span></strong></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Restart heparin (unfractionated or LMWH) 6 hours after vaginal delivery and 24 hours after cesarean section.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Warfarin therapy can also be safely resumed during breastfeeding.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The final switch from warfarin to heparin in pregnant women with cardiac disease is advised at 36 weeks of gestation to minimize the risk of bleeding complications during labor and delivery.</span></span></span></p>",
      "correct_choice_id": 23212,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6107,
      "choices": [
        {
          "id": 24397,
          "text": "<p><span style=\"font-size:12pt;\">Reduction in the risk of ovarian cancer</span></p>"
        },
        {
          "id": 24398,
          "text": "<p><span style=\"font-size:12pt;\">Ectopic pregnancy</span></p>"
        },
        {
          "id": 24399,
          "text": "<p><span style=\"font-size:12pt;\">Protection against sexually transmitted diseases including HIV</span></p>"
        },
        {
          "id": 24400,
          "text": "<p><span style=\"font-size:12pt;\">Reduction in the risk of endometrial cancer</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The non-contraceptive uses of oral contraceptives include all of the following except?</span>(INICET NOV 2022)</p>",
      "unique_key": "Q9437107",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585500,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Protection against sexually transmitted diseases including HIV</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The non-contraceptive benefits of combined oral contraceptive pills (COCPs) include:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Reduction in the risk of ovarian cancer</strong>: COCPs reduce the incidence of ovarian cancer.</span></li><li><span style=\"font-size:12pt;\"><strong>Reduction in the risk of endometrial cancer</strong>: COCPs lower the incidence of endometrial malignancy.</span></li><li><span style=\"font-size:12pt;\"><strong>Reduction in the incidence of ectopic pregnancy</strong>: COCPs decrease the likelihood of ectopic pregnancies by preventing ovulation and thickening cervical mucus.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">However, COCPs do not provide protection against sexually transmitted diseases (STDs), including HIV.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Reduction in the risk of ovarian cancer</strong>: COCPs are known to reduce the incidence of ovarian cancer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Ectopic pregnancy</strong>: COCPs lower the risk of ectopic pregnancy by preventing ovulation and thickening the cervical mucus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Reduction in the risk of endometrial cancer</strong>: COCPs decrease the risk of endometrial cancer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Combined oral contraceptive pills do not provide protection against sexually transmitted diseases (STDs), including HIV.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: William’s textbook of gynecology 3<sup>rd</sup> edition pg 124, Dutta’s textbook of gynecology 6<sup>th</sup> edition pg 489</strong></span></p>",
      "correct_choice_id": 24399,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 56961,
      "choices": [
        {
          "id": 227233,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Continue warfarin</span></span></span></p>"
        },
        {
          "id": 227234,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Switch to LMWH</span></span></span></p>"
        },
        {
          "id": 227235,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Immediate caesarean</span></span></span></p>"
        },
        {
          "id": 227236,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">&nbsp;Immediate IOL</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A primigravida presents at 37 weeks. She is a known case of heart disease with a prosthetic valve on warfarin. What is the next best step?&nbsp;</span></span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(NEET PG 2024)</span></span></p>",
      "unique_key": "Q7066339",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585458,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Switch to LMWH</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient is a 37-week pregnant woman with a known case of heart disease and a prosthetic valve, currently on warfarin. In pregnant patients with prosthetic heart valves, anticoagulation management is crucial to prevent thromboembolic complications. Warfarin is typically avoided in the late third trimester due to the risk of fetal bleeding and other complications during delivery. It is recommended to switch from warfarin to heparin (usually low molecular weight heparin, LMWH) at around 36 weeks of gestation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Since the patient is still on warfarin at 37 weeks, the immediate action is to switch to LMWH to reduce the risks associated with warfarin during labor and delivery. <strong>Before planning an induction of labor (IOL) or cesarean section, heparin should be stopped 12-24 hours before the planned delivery to minimize the risk of bleeding.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Continue warfarin</span></strong><span style=\"font-size:12.0pt\">: Continuing warfarin at this stage is inappropriate because it increases the risk of bleeding for both the mother and the fetus during labor or delivery. Warfarin crosses the placenta and poses significant risks during the peripartum period.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Immediate cesarean</span></strong><span style=\"font-size:12.0pt\">: There is no immediate indication for a cesarean section based on her anticoagulation status alone. Cesarean delivery would only be indicated for obstetric reasons. Moreover, performing surgery while the patient is on warfarin increases the risk of severe bleeding complications.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Immediate IOL (Induction of Labor)</span></strong><span style=\"font-size:12.0pt\">: Immediate induction of labor is not the first step as the patient is still on warfarin, which poses a bleeding risk. Before planning any delivery method, it is essential to switch to heparin and allow a safe window without anticoagulation before proceeding.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In pregnant women with prosthetic heart valves on warfarin, switch to low molecular weight heparin (LMWH) at 36 weeks to reduce the risk of complications during delivery, and stop heparin 12-24 hours before planned delivery.</span></span></span></p>",
      "correct_choice_id": 227234,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6039,
      "choices": [
        {
          "id": 24126,
          "text": "<p><span style=\"font-size:12pt;\">1 or 2 doses</span></p>"
        },
        {
          "id": 24127,
          "text": "<p><span style=\"font-size:12pt;\">2 doses</span></p>"
        },
        {
          "id": 24128,
          "text": "<p><span style=\"font-size:12pt;\">1 dose</span></p>"
        },
        {
          "id": 24129,
          "text": "<p><span style=\"font-size:12pt;\">3 doses</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Recommended HPV vaccination schedule for 9- to 14-year-olds according to WHO SAGE guidelines is:&nbsp;</span>(INICET MAY 2022)</p>",
      "unique_key": "Q3093181",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585471,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A) 1 or 2 doses</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Recommended Schedule:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\"><strong>One or Two-Dose Schedule</strong>:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:16px;\"><strong>One dose</strong> is considered sufficient for healthy individuals aged 9–14 years.</span></li><li><span style=\"font-size:16px;\">Alternatively, a <strong>two-dose schedule</strong> may be administered, with the second dose given <strong>6–12 months</strong> after the first.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Key Considerations:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\"><strong>Primary Target Group</strong>: Girls aged <strong>9–14 years</strong>, ideally before the onset of sexual activity.</span></li><li><span style=\"font-size:16px;\"><strong>Immunocompromised Individuals</strong>: Should receive <strong>at least two doses</strong>, and where feasible, <strong>three doses</strong>, regardless of age.</span></li><li><span style=\"font-size:16px;\"><strong>Vaccination of Boys</strong>: While the primary focus is on girls, vaccinating boys is recommended where feasible and affordable to enhance herd immunity and prevent HPV-related diseases in males.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The WHO SAGE guidelines recommend 1 or 2 doses of HPV vaccine for 9- to 14-year-olds.</span></p>",
      "correct_choice_id": 24126,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5950,
      "choices": [
        {
          "id": 23770,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3</span></p>"
        },
        {
          "id": 23771,
          "text": "<p><span style=\"font-size:12.0pt;\">2, 3, 4</span></p>"
        },
        {
          "id": 23772,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 3, 4</span></p>"
        },
        {
          "id": 23773,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A teenage girl presented with irregular cycles and increased facial hair. Her ovaries showed increased volume. Which of the following are used in the first line treatment?&nbsp;</span>(INICET MAY 2021)</p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Laparoscopic ovarian drilling</span></li><li><span style=\"font-size:12.0pt;\">Anti-androgens</span></li><li><span style=\"font-size:12.0pt;\">Lifestyle modifications</span></li><li><span style=\"font-size:12.0pt;\">Combined oral contraceptive pills</span></li></ol>",
      "unique_key": "Q1176513",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585485,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) 2, 3, 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">The clinical presentation of irregular menstrual cycles and increased facial hair, combined with increased ovarian volume, is suggestive of <strong>polycystic ovarian syndrome (PCOS)</strong>. The first-line treatment options for PCOS typically include:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Anti-androgens</strong> (2): These medications help reduce symptoms related to excess androgens, such as facial hair and acne. Common examples include spironolactone.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Lifestyle modifications</strong> (3): These are crucial for managing PCOS. Weight loss and exercise can improve insulin sensitivity and help regulate menstrual cycles.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Combined oral contraceptive pills</strong> (4): These are used to regulate menstrual cycles, reduce hyperandrogenism symptoms (like hirsutism), and provide endometrial protection.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Laparoscopic ovarian drilling</strong> (1): This is a surgical procedure used to treat PCOS, but it is generally considered a second-line treatment. It is typically performed when medical management fails to achieve the desired results.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">The first-line treatments for PCOS include anti-androgens, lifestyle modifications, and combined oral contraceptive pills.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Page no 460, DC Dutta’s Textbook of Gynecology 6<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23771,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47874,
      "choices": [
        {
          "id": 191091,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3, 4</span></p>"
        },
        {
          "id": 191092,
          "text": "<p><span style=\"font-size:12.0pt;\">2, 4, 1, 3</span></p>"
        },
        {
          "id": 191093,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 3, 2, 4</span></p>"
        },
        {
          "id": 191094,
          "text": "<p><span style=\"font-size:12.0pt;\">2, 1, 4, 3</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The correct order of events of lactation in the puerperium are?&nbsp;(FMGE JANUARY 2024)</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Lactogenesis</span></li><li><span style=\"font-size:12.0pt;\">Mammogenesis</span></li><li><span style=\"font-size:12.0pt;\">Galactopoiesis</span></li><li><span style=\"font-size:12.0pt;\">Galactokinesis</span></li></ol><p>&nbsp;</p>",
      "unique_key": "Q8966046",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585459,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) 2, 1, 4, 3</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The process of lactation involves several stages, each with specific physiological changes. Understanding these stages helps in comprehending the sequence of events that occur from the preparation of the breast during pregnancy to the maintenance of milk production.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">2. <strong>Mammogenesis</strong>: This is the first stage, involving the development and growth of the mammary glands in preparation for lactation. It occurs during pregnancy when the breast tissue proliferates and differentiates under the influence of hormones such as estrogen and progesterone.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">1. <strong>Lactogenesis</strong>: This stage refers to the initiation of milk production, which begins around the time of birth. Lactogenesis is divided into two phases:</span><br>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Lactogenesis I: Occurs during pregnancy when the mammary gland is capable of producing some milk.</span></li><li><span style=\"font-size:12.0pt;\">Lactogenesis II: Occurs postpartum when copious milk secretion begins, typically around 2-3 days after delivery, driven by the sudden drop in progesterone and the increase in prolactin.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">4. <strong>Galactokinesis</strong>: This stage involves the ejection or movement of milk from the alveoli to the nipple. It is facilitated by the let-down reflex, which is triggered by the hormone oxytocin. Oxytocin causes the myoepithelial cells around the alveoli to contract, expelling the milk into the ducts and out through the nipple.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">3. <strong>Galactopoiesis</strong>: This final stage refers to the maintenance of milk production. It is sustained by the regular removal of milk from the breast, either through breastfeeding or pumping, which maintains prolactin levels and keeps the milk supply ongoing.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The correct sequence of events in lactation during the puerperium is: Mammogenesis (breast development), Lactogenesis (initiation of milk production), Galactokinesis (milk ejection), and Galactopoiesis (maintenance of milk production).</span></p>",
      "correct_choice_id": 191094,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47885,
      "choices": [
        {
          "id": 191135,
          "text": "<p><span style=\"font-size:12.0pt;\">Chloroquine + Primaquine</span></p>"
        },
        {
          "id": 191136,
          "text": "<p><span style=\"font-size:12.0pt;\">Chloroquine</span></p>"
        },
        {
          "id": 191137,
          "text": "<p><span style=\"font-size:12.0pt;\">Quinine</span></p>"
        },
        {
          "id": 191138,
          "text": "<p><span style=\"font-size:12.0pt;\">Artesunate</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Drug of choice for malaria (plasmodium vivax) in pregnancy?&nbsp;(FMGE JANUARY 2024)</span></p>",
      "unique_key": "Q5721263",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585466,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Chloroquine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The treatment of malaria in pregnancy, especially caused by Plasmodium vivax, requires special consideration due to the potential effects on both the mother and the fetus. The key points are:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Chloroquine</strong>: Chloroquine is the <strong>drug of choice for treating Plasmodium vivax malaria</strong> in pregnant women. It is effective and safe during pregnancy.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Alternative Drugs</strong>: If there is resistance to chloroquine<strong>, quinine can be used as a secondary option.</strong></span></li><li><span style=\"font-size:12.0pt;\">For Plasmodium <strong>falciparum malaria, artesunate is the preferred drug,</strong> followed by quinine, both of which can be safely used during pregnancy.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Chloroquine + Primaquine</strong>: This combination is not used in pregnancy due to the contraindication of primaquine. Primaquine is <strong>contraindicated in pregnancy</strong> because it can cause hemolytic anemia in the fetus, especially in those with G6PD deficiency. It is not used for radical cure in pregnant women and is deferred until after delivery.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>C</strong>. <strong>Quinine</strong>: While quinine can be used if there is resistance to chloroquine, it is not the first-line treatment for Plasmodium vivax.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>D. Artesunate</strong>: Artesunate is the drug of choice for Plasmodium falciparum malaria but not for Plasmodium vivax in pregnancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Treatment of Malaria in Pregnancy</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Chloroquine – 600 mg base P.O. followed by 300 mg 12 hours later. Then 300 mg daily for next 2 days.</span></li><li><span style=\"font-size:12.0pt;\">To prevent relapse during pregnancy, 300 mg is to be taken weekly until delivery.</span></li><li><span style=\"font-size:12.0pt;\">For radical cure, primaquine should be postponed until pregnancy is over.</span></li><li><span style=\"font-size:12.0pt;\">Parasites resistant to chloroquine should be given quinine under supervision.</span></li><li><span style=\"font-size:12.0pt;\">Patients with severe anemia may need blood transfusion.</span></li><li><span style=\"font-size:12.0pt;\">Folic acid 10 mg should be given daily to prevent megaloblastic anemia.</span></li><li><span style=\"font-size:12.0pt;\">Complicated malaria: Artesunate IV 2.4 mg/kg at 0, 12 and 24 hours, then daily thereafter. Oral therapy (2 mg/kg) is started when the patient is stable.</span></li><li><span style=\"font-size:12.0pt;\">Alternatively, Quinine IV followed by oral therapy is given.</span></li></ul>",
      "correct_choice_id": 191136,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47295,
      "choices": [
        {
          "id": 188791,
          "text": "<p><span style=\"font-size:12.0pt;\">Anemia</span></p>"
        },
        {
          "id": 188792,
          "text": "<p><span style=\"font-size:12.0pt;\">Heart disease</span></p>"
        },
        {
          "id": 188793,
          "text": "<p><span style=\"font-size:12.0pt;\">Pre-eclampsia</span></p>"
        },
        {
          "id": 188794,
          "text": "<p><span style=\"font-size:12.0pt;\">Embolism</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is a direct cause of maternal death? (FMGE JULY 2023)</span></p>",
      "unique_key": "Q8510076",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585486,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Pre-eclampsia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Maternal deaths can be classified into direct and indirect causes. Direct causes are those that result from complications of pregnancy, labor, or the postpartum period, whereas indirect causes are conditions that are exacerbated by pregnancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Pre-eclampsia</strong>: This is a direct cause of maternal death. Pre-eclampsia is a hypertensive disorder of pregnancy that can lead to severe complications such as eclampsia, HELLP syndrome, stroke, and organ failure, all of which can directly result in maternal mortality.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Anemia</strong>: This is considered an <strong>indirect cause</strong> of maternal death. While severe anemia can exacerbate complications during pregnancy and childbirth, it is not a direct cause but increases the risk of infections, hemorrhage, and other complications.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Heart disease</strong>: This is also an <strong>indirect cause</strong> of maternal death. Pre-existing heart disease can worsen during pregnancy due to the increased cardiovascular demands, but it is not a complication arising directly from pregnancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Embolism</strong>: Pulmonary embolism is considered an indirect cause of maternal death when it occurs due to pregnancy-related factors like deep vein thrombosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Pre-eclampsia is a direct cause of maternal death, directly associated with complications arising from pregnancy, labor, or the postpartum period.</span></p>",
      "correct_choice_id": 188793,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 21803,
      "choices": [
        {
          "id": 87176,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dichorionic Diamniotic</span></span></span></p>"
        },
        {
          "id": 87177,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dichorionic Monoamniotic</span></span></span></p>"
        },
        {
          "id": 87178,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Monochorionic Monoamniotic</span></span></span></p>"
        },
        {
          "id": 87179,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Conjoined twins</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following can be expected if division of zygote occurs between 8 &ndash; 12 days after fertilization?</span></span>&nbsp;(FMGE JANUARY 2023)</p>",
      "unique_key": "Q2024704",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585479,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Monochorionic Monoamniotic</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/12/screenshot-2024-08-12-113846.png\" style=\"height:368px; width:1000px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Dichorionic Diamniotic:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Occurs when the division of the zygote happens within the first 3 days after fertilization.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Dichorionic Monoamniotic:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is not a typical classification in twin pregnancies.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Conjoined twins:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Result from the division of the zygote occurring after the 13th day of fertilization.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Monochorionic monoamniotic twins result from the division of the zygote occurring between 8 to 12 days after fertilization.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: </span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Williams Textbook of Obstetrics 24<sup>th</sup> edition </span></strong><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">page 893</span></strong></span></span></p>",
      "correct_choice_id": 87178,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5768,
      "choices": [
        {
          "id": 23043,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">500</span></span></span></p>"
        },
        {
          "id": 23044,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">300</span></span></span></p>"
        },
        {
          "id": 23045,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Continue same diet</span></span></span></p>"
        },
        {
          "id": 23046,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">600</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A pregnant lady of 49 kg is in her first trimester. What are her additional calorie requirements in this trimester?&nbsp;</span></span><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(INICET NOV 2017)</span></span></span></span></p>",
      "unique_key": "Q5419551",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585464,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Continue same diet</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pregnancy requires an additional 80,000 Kcal; mostly in the latter half. During the first trimester, there is no need for additional calories. The caloric increase is recommended as follows:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">0 Kcal in 1st trimester</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">340 Kcal in 2nd trimester</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">452 Kcal in 3rd trimester</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In this question, extra calories in the 1st trimester are asked, so the answer will be no additional requirement.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">There are no additional calorie requirements in the first trimester of pregnancy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Page no 487, Williams Obstetrics 26<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 23045,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5766,
      "choices": [
        {
          "id": 23035,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fentanyl</span></span></span></p>"
        },
        {
          "id": 23036,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Naloxone</span></span></span></p>"
        },
        {
          "id": 23037,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Morphine</span></span></span></p>"
        },
        {
          "id": 23038,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bupivacaine</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following drug must always be available for emergency use in labor ward if a patient is on opioid analgesic?&nbsp;</span></span><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(INICET NOV 2017)</span></span></span></span></p>",
      "unique_key": "Q9671550",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585462,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Naloxone</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Naloxone is a narcotic antagonist capable of reversing respiratory depression induced by opioid narcotics. It acts by displacing the narcotic from specific receptors in the central nervous system, thus reversing the effects of the opioid, including respiratory depression. This makes it an essential drug to have on hand in the labor ward when a patient is receiving opioid analgesics.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Fentanyl:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is an opioid analgesic used for pain management, not for reversing opioid effects.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Morphine:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is another opioid analgesic and would not be used to counteract the effects of other opioids.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Bupivacaine:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is a local anesthetic used for epidural anesthesia, not an opioid antagonist.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Naloxone must always be available in the labor ward for emergency use when a patient is on opioid analgesic to promptly reverse opioid-induced respiratory depression.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 546, DC Dutta&rsquo;s Textbook of Obstetrics 8<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 23036,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 56965,
      "choices": [
        {
          "id": 227249,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Methyl ergometrine</span></span></span></p>"
        },
        {
          "id": 227250,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Carboprost</span></span></span></p>"
        },
        {
          "id": 227251,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Misoprostol</span></span></span></p>"
        },
        {
          "id": 227252,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Oxytocin</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Drug contraindicated in asthma in PPH (Postpartum Hemorrhage) case?&nbsp;</span></span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(NEET PG 2024)</span></span></p>",
      "unique_key": "Q2602421",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585461,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Carboprost</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Carboprost is a prostaglandin F2 alpha analog that is <strong>commonly used to manage atonic postpartum hemorrhage </strong>by inducing strong uterine contractions. However, it is contraindicated in patients with asthma because it can cause bronchoconstriction and exacerbate asthma symptoms. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Carboprost is also contraindicated in patients with cardiac arrhythmias due to its potent cardiovascular effects.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Methyl ergometrine:</span></strong><span style=\"font-size:12.0pt\"> This drug is used for the management of postpartum hemorrhage due to its uterotonic properties, but it does not specifically affect asthma and is not contraindicated in asthmatic patients.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Misoprostol:</span></strong><span style=\"font-size:12.0pt\"> Misoprostol, a prostaglandin E1 analog, is also used in postpartum hemorrhage for uterine contraction. It does not have the same bronchoconstrictive effects as Carboprost and is not contraindicated in asthma.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Oxytocin:</span></strong><span style=\"font-size:12.0pt\"> Oxytocin is a common uterotonic agent used in postpartum hemorrhage management. It has no known bronchoconstrictive properties and is safe for use in asthmatic patients.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Carboprost (PGF2 alpha) is contraindicated in patients with asthma due to its bronchoconstrictive effects.</span></span></span></p>",
      "correct_choice_id": 227250,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5994,
      "choices": [
        {
          "id": 23946,
          "text": "<p><span style=\"font-size:12pt;\">Selective fetal growth restriction</span></p>"
        },
        {
          "id": 23947,
          "text": "<p><span style=\"font-size:12pt;\">Polyhydramnios</span></p>"
        },
        {
          "id": 23948,
          "text": "<p><span style=\"font-size:12pt;\">Twin to twin transfusion syndrome</span></p>"
        },
        {
          "id": 23949,
          "text": "<p><span style=\"font-size:12pt;\">Neural tube defects</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following complication is specific to Monochorionic twins?&nbsp;</span>&nbsp;(INICET NOV 2021)</p>",
      "unique_key": "Q5962018",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585509,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Twin to twin transfusion syndrome</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Complications specific to monochorionic twins are:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Twin to twin transfusion syndrome (TTTS)</strong>: This is a specific complication seen in monochorionic twins. There is a donor twin and a recipient twin; the donor is anemic and pale with oligohydramnios, while the recipient is polycythemic and may have circulatory overload, ascites, and hydrops. Quintero's staging is used for TTTS, and the treatment involves laser ablation of vessels.</span></li><li><span style=\"font-size:12pt;\"><strong>TRAP sequence (Twin Reversed Arterial Perfusion)</strong>: This is another specific complication seen in monochorionic twins, involving an acardiac twin.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Selective fetal growth restriction</strong>: While this can occur in monochorionic twins, it is not specific to them.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Polyhydramnios</strong>: This can be seen in various conditions and is not specific to monochorionic twins.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Neural tube defects</strong>: These can occur in any pregnancy and are not specific to monochorionic twins.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Thus, options A, B, and D are not specific complications of monochorionic twins.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: William’s textbook of obstetrics 24<sup>th</sup> edition pg904,905</strong></span></p>",
      "correct_choice_id": 23948,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6106,
      "choices": [
        {
          "id": 24393,
          "text": "<p><span style=\"font-size:12pt;\">Additional 300kcal in 2nd trimester</span></p>"
        },
        {
          "id": 24394,
          "text": "<p><span style=\"font-size:12pt;\">Additional 300kcal in 1st trimester</span></p>"
        },
        {
          "id": 24395,
          "text": "<p><span style=\"font-size:12pt;\">Additional 300kcal in 3rd trimester</span></p>"
        },
        {
          "id": 24396,
          "text": "<p><span style=\"font-size:12pt;\">Additional 300kcal throughout the pregnancy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A primigravida woman at 12 weeks of gestation comes to the antenatal clinic for nutritional advice. Which of the following will you recommend?&nbsp;</span>(NEET PG 2022)</p>",
      "unique_key": "Q3663056",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585503,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Additional 300kcal in 2nd trimester</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">For a pregnant woman, additional caloric intake recommendations vary by trimester.</span></li><li><span style=\"font-size:12pt;\">As per Williams Obstetrics:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">In the first trimester, no extra calories are required.</span></li><li><span style=\"font-size:12pt;\">In the second trimester, it is recommended to increase by approximately 340 kcal per day.</span></li><li><span style=\"font-size:12pt;\">In the third trimester, it is recommended to increase by approximately 452 kcal per day.</span></li></ul></li><li><span style=\"font-size:12pt;\">According to the Indian Council of Medical Research (ICMR), an additional intake of 300 kcal during the second and third trimesters of pregnancy is recommended.</span></li><li><span style=\"font-size:12pt;\">Therefore, the recommendation of an additional 300 kcal in the second trimester is appropriate.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Additional 300kcal in 1st trimester:&nbsp;</strong>No extra calories are recommended in the first trimester.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Additional 300kcal in 3rd trimester:&nbsp;</strong>The recommendation for the third trimester is an increase of approximately 452 kcal per day.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Additional 300kcal throughout the pregnancy:&nbsp;</strong>Caloric requirements vary by trimester, with no extra calories needed in the first trimester, and specific increases for the second and third trimesters.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Understand the caloric requirements and recommendations for each trimester of pregnancy to ensure adequate maternal and fetal nutrition.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page 483, Williams Obstetrics 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 24393,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6108,
      "choices": [
        {
          "id": 24401,
          "text": "<p><span style=\"font-size:12pt;\">Positive fetal fibronectin test</span></p>"
        },
        {
          "id": 24402,
          "text": "<p><span style=\"font-size:12pt;\">Membranes bulging into the vagina</span></p>"
        },
        {
          "id": 24403,
          "text": "<p><span style=\"font-size:12pt;\">Ruptured membranes</span></p>"
        },
        {
          "id": 24404,
          "text": "<p><span style=\"font-size:12pt;\">Advanced maternal age</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 39 year G2P1 presents at 18 weeks 5 days for her routine targeted fetal anomaly ultrasound. The fetal anatomy appears normal, but the cervical length is 15mm. Despite being counselled that there is no clear proven benefit for the same; the patient insisted on a cervical cerclage. Which of the following is a complete contra-indication to cerclage? </span>(NEET PG 2022)</p>",
      "unique_key": "Q3840944",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585505,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C) Ruptured membranes</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\"><strong>Ruptured Membranes:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:16px;\">Ruptured membranes are a complete contraindication to cerclage. When the membranes are ruptured, there is an increased risk of infection and complications, making the procedure unsafe.</span></li><li><span style=\"font-size:16px;\"><strong>Ruptured membranes are a complete contraindication to cerclage. When the membranes are ruptured, there is an increased risk of infection and complications, making the procedure unsafe.</strong></span></li><li><span style=\"font-size:16px;\">Cerclage involves stitching the cervix closed to prevent premature birth, which is not advisable when the protective amniotic sac is compromised.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Absolute Contraindications to Cervical Cerclage</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\"><strong>Active labor</strong></span></li><li><span style=\"font-size:16px;\"><strong>Clinical signs of chorioamnionitis</strong></span></li><li><span style=\"font-size:16px;\"><strong>Preterm premature rupture of membranes (PPROM)</strong></span></li><li><span style=\"font-size:16px;\"><strong>Fetal demise (IUFD)</strong></span></li><li><span style=\"font-size:16px;\"><strong>Major fetal anomalies incompatible with life</strong></span></li><li><span style=\"font-size:16px;\"><strong>Significant vaginal bleeding due to placental abruption</strong></span></li><li><span style=\"font-size:16px;\"><strong>ruptured membranes&nbsp;</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Positive fetal fibronectin test: </strong>A positive fetal fibronectin test indicates an increased risk of preterm labor but is not an absolute contraindication to cerclage.&nbsp;This test measures the presence of fetal fibronectin, a protein that acts as a \"glue\" during pregnancy, keeping the amniotic sac attached to the lining of the uterus.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Membranes bulging into the vagina: </strong>While bulging membranes present a high-risk situation, they are not an absolute contraindication to cerclage. In some cases, cerclage can still be performed with careful management.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Advanced maternal age: </strong>Advanced maternal age is not a contraindication to cerclage. While it may increase the overall risk profile of the pregnancy, it does not specifically contraindicate the procedure.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Ruptured membranes are a complete contraindication to cervical cerclage due to the increased risk of infection and complications.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Ref: Page 543, Williams Obstetrics 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 24403,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20501,
      "choices": [
        {
          "id": 81966,
          "text": "<p><span style=\"font-size:12pt;\">Increased intracranial pressure</span></p>"
        },
        {
          "id": 81967,
          "text": "<p><span style=\"font-size:12pt;\">IVC compression</span></p>"
        },
        {
          "id": 81968,
          "text": "<p><span style=\"font-size:12pt;\">Heavy meals</span></p>"
        },
        {
          "id": 81969,
          "text": "<p><span style=\"font-size:12pt;\">Excessive venous pooling at the feet</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A pregnant woman at 36 weeks of gestation presents to you with complaints of feeling light-headedness and dizziness when she lies on her back and feels relieved if she lies on her side or when walks. What is the most likely reason behind this?&nbsp;</span>(NEET PG 2023)</p>",
      "unique_key": "Q2892728",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585470,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) IVC compression</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The symptoms of light-headedness and dizziness that the pregnant woman experiences when lying on her back, which are relieved by lying on her side or walking, are indicative of inferior vena cava (IVC) compression. In the supine position during late pregnancy, the gravid uterus compresses the IVC, which can decrease venous return to the heart. This condition, known as supine hypotensive syndrome, leads to reduced cardiac output and can cause symptoms such as dizziness, light-headedness, and a decreased supply of oxygen and nutrients to vital organs.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Supine Hypotensive Syndrome:</strong> This occurs when the enlarged uterus compresses the IVC, reducing venous return to the heart, leading to symptoms like dizziness and light-headedness.</span></li><li><span style=\"font-size:12pt;\"><strong>Relief by changing position:</strong> Symptoms are relieved when the woman lies on her side or walks because these positions alleviate the pressure on the IVC, improving venous return and cardiac output.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Increased intracranial pressure:</strong> This would present with symptoms such as headache, vomiting, visual disturbances, and altered mental status, not positional dizziness relieved by lying on the side.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Heavy meals:</strong> While heavy meals can cause discomfort, they are unlikely to cause the specific positional symptoms described.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Excessive venous pooling at the feet:</strong> This might cause symptoms such as swelling and discomfort in the legs but not the specific positional dizziness described.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Inferior vena cava compression by the gravid uterus in late pregnancy can cause supine hypotensive syndrome, leading to light-headedness and dizziness when lying on the back, which is relieved by lying on the side or walking.</span></p>",
      "correct_choice_id": 81967,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5951,
      "choices": [
        {
          "id": 23774,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cusco&#39;s speculum</span></span></span></p>"
        },
        {
          "id": 23775,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">﻿﻿﻿Sims&#39; speculum</span></span></span></p>"
        },
        {
          "id": 23776,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">﻿﻿﻿Proctoscope</span></span></span></p>"
        },
        {
          "id": 23777,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">﻿﻿﻿Doyen&#39;s retractor</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Identify the instrument given below?&nbsp;</span></span>(INICET MAY 2021)</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/02/1_FFzm3FJ.jpg\" style=\"height:210px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q5342223",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585487,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Cusco&#39;s speculum</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The instrument shown in the image is Cusco&#39;s speculum.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cusco&#39;s speculum is a self-retaining bivalve speculum used for visualization of the cervix, vaginal fornices and for performing pap smear.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Advantage: Self retaining</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Disadvantage: Less space so can&rsquo;t be used for some procedures, obscures the vaginal walls so vaginal lesion may be missed</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Sim Speculum:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/26/untitled-230.jpg\" style=\"height:250px; width:250px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Proctoscope</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/26/untitled-231.jpg\" style=\"height:250px; width:250px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Doyen Retractor</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/26/untitled-232.jpg\" style=\"height:410px; width:250px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cusco&#39;s speculum is a self-retaining bivalve speculum used for visualizing the cervix and vaginal fornices.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Page no 628, DC Dutta&rsquo;s Textbook of Gynecology 6<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 23774,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "INICET",
        "InstrumentsBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6030,
      "choices": [
        {
          "id": 24090,
          "text": "<p><span style=\"font-size:12pt;\">Start colloids initially, 4 times the blood lost</span></p>"
        },
        {
          "id": 24091,
          "text": "<p><span style=\"font-size:12pt;\">Primary PPH occurs within 24 hours of childbirth</span></p>"
        },
        {
          "id": 24092,
          "text": "<p><span style=\"font-size:12pt;\">PPH is loss of &gt; 500 ml of blood in vaginal delivery</span></p>"
        },
        {
          "id": 24093,
          "text": "<p><span style=\"font-size:12pt;\">Causes include retained placenta and atony</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Which of the following statements is false regarding post-partum hemorrhage (PPH)?&nbsp;</span>(INICET MAY 2022)</p>",
      "unique_key": "Q3282176",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585467,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Start colloids initially, 4 times the blood lost</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The false statement regarding post-partum hemorrhage (PPH) is option A. T<strong>he standard practice for managing PPH is to start intravenous isotonic crystalloids rather than colloids</strong>. Colloids are generally reserved for specific situations and are not the initial choice for fluid resuscitation in PPH. The correct approach involves using crystalloids to replace lost blood volume. The recommendation is not to administer colloids at a volume four times the amount of blood lost.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/27/untitled-243.jpg\" alt=\"\" width=\"900\" height=\"387\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Primary PPH occurs within 24 hours of childbirth:</strong> This statement is true. Primary or early postpartum hemorrhage refers to blood loss occurring within the first 24 hours after delivery.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. PPH is loss of &gt; 500 ml of blood in vaginal delivery</strong>: This statement is true. Postpartum hemorrhage is defined as a blood loss greater than 500 ml following a vaginal delivery and more than 1000 ml following a cesarean section.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Causes include retained placenta and atony</strong>: This statement is true. Common causes of postpartum hemorrhage include uterine atony (failure of the uterus to contract) and retained placenta.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Initial management of post-partum hemorrhage should involve intravenous isotonic crystalloids, not colloids.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page 1894, Williams Obstetrics 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 24090,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20499,
      "choices": [
        {
          "id": 81958,
          "text": "<p><span style=\"font-size:12pt;\">Transverse vaginal septum above the vagina</span></p>"
        },
        {
          "id": 81959,
          "text": "<p><span style=\"font-size:12pt;\">Vaginal atresia</span></p>"
        },
        {
          "id": 81960,
          "text": "<p><span style=\"font-size:12pt;\">Imperforate hymen</span></p>"
        },
        {
          "id": 81961,
          "text": "<p><span style=\"font-size:12pt;\">Cervical agenesis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 16-year-old girl presents in OPD with complaints of cyclical pain in abdomen. &nbsp;On examination, a suprapubic bulge can be seen in the pelvic area. PR examination reveals a swelling in the anterior aspect. What is the most likely diagnosis? (NEET PG 2023)</span></p>",
      "unique_key": "Q1602870",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585468,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Imperforate hymen</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The given case scenario points to a diagnosis of cryptomenorrhea, due to an imperforate hymen.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Cryptomenorrhea is a condition in which menstruation occurs but is not visible due to obstruction of the outflow tract resulting in either hematometra (blood collection within the uterus) or hematocolpos (blood collection within vagina). In the long term, it may result in endometriosis, urinary retention and infertility.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>IMPERFORATE HYMEN</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Presents as cryptomenorrhea</span></li><li><span style=\"font-size:12pt;\">H/o cyclical abdominal pain/cyclical dysmenorrhea</span></li><li><span style=\"font-size:12pt;\">Local examination: bluish bulge with intact hymen</span></li><li><span style=\"font-size:12pt;\">On P/R: swelling (hematocolpos) felt along length of vagina anteriorly</span></li><li><span style=\"font-size:12pt;\">Treatment: Cruciate incision.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/10/screenshot-2024-08-10-182236.png\" alt=\"\" width=\"400\" height=\"471\"></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In Imperforate hymen, swelling is seen all along the length of the vagina on PR examination as there is hematocolpos (blood in the vagina)</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Transverse vaginal septum</strong>: Transverse vaginal septum is a Müllerian anomaly. On examination, blind vagina is found. No tense blue hymen and cough impulse will be absent. Diagnosis can be confirmed by MRI</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Vaginal atresia</strong>: If vaginal introitus is not seen, then it’s vaginal atresia</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Cervical agenesis</strong>: Cervical agenesis will show absence of a cervix is on examination.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Imperforate hymen presents with cryptomenorrhea, characterized by cyclical abdominal pain and hematocolpos due to obstruction of menstrual flow, with a suprapubic bulge and anterior swelling palpable on PR examination.</span></p>",
      "correct_choice_id": 81960,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6134,
      "choices": [
        {
          "id": 24505,
          "text": "<p><span style=\"font-size:12pt;\">levonorgesterel IUD</span></p>"
        },
        {
          "id": 24506,
          "text": "<p><span style=\"font-size:12pt;\">Copper-T 380A</span></p>"
        },
        {
          "id": 24507,
          "text": "<p><span style=\"font-size:12pt;\">Mala N</span></p>"
        },
        {
          "id": 24508,
          "text": "<p><span style=\"font-size:12pt;\">Norethisterone enanthate - depot injection</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 24-year-old lactating female with an 18-month-old child comes with a history of irregular, heavy bleeding seeking contraceptive advice. Which is the contraceptive of choice?&nbsp;</span>(NEET PG 2022)</p>",
      "unique_key": "Q1261762",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585515,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A) levonorgesterel IUD</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\"><strong>Suitable during lactation</strong></span><ul><li><span style=\"font-size:16px;\">LNG-IUS is a <strong>progestin-only</strong> method</span></li><li><span style=\"font-size:16px;\"><strong>Does not reduce milk production</strong> (unlike estrogen-containing pills)</span></li></ul></li><li><span style=\"font-size:16px;\"><strong>Controls heavy menstrual bleeding (menorrhagia)</strong></span><ul><li><span style=\"font-size:16px;\">LNG-IUS <strong>reduces menstrual blood loss by 70–90%</strong></span></li><li><span style=\"font-size:16px;\">Improves <strong>hemoglobin levels</strong> and quality of life</span></li></ul></li><li><span style=\"font-size:16px;\"><strong>Long-acting and reversible</strong></span><ul><li><span style=\"font-size:16px;\">Provides <strong>effective contraception for up to 5 years</strong></span></li><li><span style=\"font-size:16px;\">Fertility returns quickly after removal</span></li></ul></li><li><span style=\"font-size:16px;\"><strong>Low maintenance</strong></span><ul><li><span style=\"font-size:16px;\">No daily action required</span></li><li><span style=\"font-size:16px;\">Ideal for busy mothers with young children</span></li></ul></li><li><span style=\"font-size:16px;\"><strong>High efficacy</strong></span><ul><li><span style=\"font-size:16px;\">Failure rate &lt;0.2% per year</span></li><li><span style=\"font-size:16px;\">One of the most effective reversible methods</span></li></ul></li><li><span style=\"font-size:16px;\"><strong>WHO Medical Eligibility Criteria (MEC)</strong></span><ul><li><span style=\"font-size:16px;\"><strong>Category 1 (no restriction)</strong> after 6 weeks postpartum</span></li><li><span style=\"font-size:16px;\">Safe for breastfeeding women</span></li></ul></li><li><span style=\"font-size:16px;\"><strong>Fewer systemic side effects</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:16px;\">Hormone acts locally in the uterus</span></li><li><span style=\"font-size:16px;\">Minimal systemic absorption</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Copper-T 380A</strong>: Copper-T 380A is a non-hormonal intrauterine device that may exacerbate heavy menstrual bleeding and would not be suitable for a patient already experiencing heavy bleeding.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Mala N</strong>:&nbsp;Mala N is also a possible contraceptive in this situation. There is high chance of non compliance&nbsp;and missed pill. LNG IUS is better option in such cases</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Norethisterone enanthate - depot injection</strong>: Norethisterone enanthate is a progesterone-only injectable contraceptive. it may lead to delay in return to menses, and also requires follow up every 3 months for next dose, which is inconvenient.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">For a lactating woman with a history of irregular and heavy menstrual bleeding, a combined oral contraceptive pill (COC) like Mala N is the preferred choice after the first 6 months postpartum as it helps regulate menstrual cycles and reduce menstrual flow.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Ref: Page no 398, DC Dutta’s Textbook of Gynecology, 7<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 24505,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5841,
      "choices": [
        {
          "id": 23334,
          "text": "<p><span style=\"font-size:12pt;\">3 mm</span></p>"
        },
        {
          "id": 23335,
          "text": "<p><span style=\"font-size:12pt;\">4 mm</span></p>"
        },
        {
          "id": 23336,
          "text": "<p><span style=\"font-size:12pt;\">7 mm</span></p>"
        },
        {
          "id": 23337,
          "text": "<p><span style=\"font-size:12pt;\">9 mm</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the minimum endometrial thickness on transvaginal ultrasonography, above which you perform a biopsy in a case of postmenopausal bleeding?&nbsp;</span>(INICET NOV 2018)</p>",
      "unique_key": "Q6699392",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585495,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) 4 mm</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Post menopausal bleeding with a finding of endometrial thickness greater than 4 mm (5 mm or more) requires further evaluation, i.e., a biopsy of the endometrium.</span></li><li><span style=\"font-size:12pt;\">If the endometrial thickness is ≤4 mm, then malignancy is unlikely and the likely cause of bleeding being endometrial atrophy and there is no need of a biopsy.</span></li><li><span style=\"font-size:12pt;\">The most common cause of post-menopausal bleeding is atrophic endometritis</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In postmenopausal women with bleeding, an endometrial thickness greater than 4 mm on transvaginal ultrasonography should prompt further evaluation with an endometrial biopsy to rule out malignancy or other significant pathology.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: William’s textbook of gynecology 3<sup>rd</sup> edition pg 186, Dutta’s textbook of gynecology 6<sup>th</sup> edition pg 357</strong></span></p>",
      "correct_choice_id": 23335,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "CriteriaBased",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5704,
      "choices": [
        {
          "id": 22788,
          "text": "<p><span style=\"font-size:12.0pt;\">1 and 2</span></p>"
        },
        {
          "id": 22789,
          "text": "<p><span style=\"font-size:12.0pt;\">Only 3</span></p>"
        },
        {
          "id": 22790,
          "text": "<p><span style=\"font-size:12.0pt;\">2 and 3</span></p>"
        },
        {
          "id": 22791,
          "text": "<p><span style=\"font-size:12.0pt;\">3 and 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following cannot cross the placenta?</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">(NEET PG 2018)</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Iron</span></li><li><span style=\"font-size:12.0pt;\">Albumin</span></li><li><span style=\"font-size:12.0pt;\">Immunoglobulin M</span></li><li><span style=\"font-size:12.0pt;\">Immunoglobulin G</span></li></ol>",
      "unique_key": "Q5683983",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585491,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) 2 and 3</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">High molecular weight substances such as <strong>proteins (e.g., albumin, IgM, IgA) cannot cross the placenta.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>1</strong>: Iron can cross the placenta via active transport mechanisms, making this option incorrect.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>4</strong>: Immunoglobulin G<strong> (IgG) can cross</strong> the placenta through endocytosis and exocytosis mechanisms, making this option incorrect.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">High molecular weight substances such as albumin and <strong>Immunoglobulin M (IgM) cannot cross</strong> the placenta.</span></p>",
      "correct_choice_id": 22790,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5839,
      "choices": [
        {
          "id": 23326,
          "text": "<p><span style=\"font-size:12pt;\">USG to see cervical length</span></p>"
        },
        {
          "id": 23327,
          "text": "<p><span style=\"font-size:12pt;\">Cervical Cerclage</span></p>"
        },
        {
          "id": 23328,
          "text": "<p><span style=\"font-size:12pt;\">Complete Bed rest</span></p>"
        },
        {
          "id": 23329,
          "text": "<p><span style=\"font-size:12pt;\">Abdominal cerclage</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A G3P2L0 presents with 9 weeks of amenorrhea. She has a history of conization being done one year ago and is currently on follow-up, with no recurrence on PAP smear. She also has the history of preterm labor at 30 and 32 weeks. What is the next step of management?&nbsp;</span>(INICET NOV 2018)</p>",
      "unique_key": "Q1377356",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585493,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) USG to see cervical length</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">This patient has several risk factors for preterm labor, including a history of previous preterm births and cervical conization. The appropriate next step in management is to perform a transvaginal ultrasound (USG) to measure the cervical length at 11-14 weeks of gestation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Key Points:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Cervical length measurement:</strong> If the cervix is found to be short (less than 2.5 cm), with or without funneling of the internal os, cervical cerclage may be indicated.</span></li><li><span style=\"font-size:12pt;\"><strong>Progesterone supplementation:</strong> If the cervical length is normal, the patient should be started on progesterone and serial cervical length measurements should be continued.</span></li><li><span style=\"font-size:12pt;\"><strong>Cervical cerclage:</strong> This is a procedure where a suture is placed around the cervix to prevent or delay preterm birth. It can be done via the vaginal route using techniques like McDonald’s or Shirodkar's.</span></li><li><span style=\"font-size:12pt;\"><strong>Abdominal cerclage:</strong> This is considered for patients with a prior failed vaginal cerclage.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Cervical Cerclage:</strong> While cerclage may be necessary, it should be based on the findings of cervical length measurement. Immediate cerclage without assessment is not recommended.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Complete Bed rest:</strong> Bed rest alone is not an effective strategy for preventing preterm labor and is not indicated without further assessment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Abdominal cerclage:</strong> This is reserved for patients with a history of failed vaginal cerclage and is not the first-line approach.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">For a patient with risk factors for preterm labor, including a history of cervical conization and previous preterm births, the next step is to perform a transvaginal ultrasound to measure cervical length at 11-14 weeks of gestation. Based on the findings, appropriate interventions, such as cervical cerclage or progesterone supplementation, can be considered.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: William’s textbook of obstetrics 26<sup>th</sup> edition pg2094</strong></span></p>",
      "correct_choice_id": 23326,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5808,
      "choices": [
        {
          "id": 23202,
          "text": "<p><span style=\"font-size:12pt;\">Immediate termination</span></p>"
        },
        {
          "id": 23203,
          "text": "<p><span style=\"font-size:12pt;\">Give surfactant and wait till 36 weeks</span></p>"
        },
        {
          "id": 23204,
          "text": "<p><span style=\"font-size:12pt;\">Do Doppler everyday to check for reversion</span></p>"
        },
        {
          "id": 23205,
          "text": "<p><span style=\"font-size:12pt;\">Terminate after 37 weeks</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A female presents with 35 weeks and 3 days of gestation, AFI = 5 and there is no end-diastolic blood flow. What is the management?&nbsp;</span>(INICET MAY 2018)</p>",
      "unique_key": "Q4566498",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585481,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Immediate termination</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The scenario described indicates fetal compromise, specifically with the findings of oligohydramnios (AFI = 5) and absent end-diastolic flow in the umbilical artery Doppler. These are signs of severe placental insufficiency and fetal distress.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Absent or Reversed End-Diastolic Flow:</strong> This is a critical finding on Doppler ultrasound indicating severe fetal compromise. The absence of end-diastolic flow in the umbilical artery suggests that the fetus is not receiving adequate blood flow, leading to an increased risk of hypoxia and stillbirth.</span></li><li><span style=\"font-size:12pt;\"><strong>Management:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\"><strong>Immediate Termination:</strong> For pregnancies beyond 34 weeks, immediate delivery is indicated to prevent further fetal compromise. This is because the risks of continuing the pregnancy outweigh the benefits, given the significant risk of fetal hypoxia and potential demise.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Give surfactant and wait till 36 weeks:</strong> This is not appropriate because the immediate risk to the fetus requires prompt delivery.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Do Doppler everyday to check for reversion:</strong> Continuous monitoring is insufficient in this scenario as the condition indicates severe fetal distress requiring urgent intervention.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Terminate after 37 weeks:</strong> Waiting until 37 weeks is not appropriate due to the immediate risk of fetal compromise.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In cases of severe fetal compromise indicated by absent or reversed end-diastolic flow in the umbilical artery Doppler, especially beyond 34 weeks of gestation, immediate termination of the pregnancy is warranted to prevent fetal hypoxia and potential stillbirth.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 2141, Williams Obstetrics 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23202,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5929,
      "choices": [
        {
          "id": 23686,
          "text": "<p><span style=\"font-size:12pt;\">Chronic renal disease</span></p>"
        },
        {
          "id": 23687,
          "text": "<p><span style=\"font-size:12pt;\">Thromboembolism</span></p>"
        },
        {
          "id": 23688,
          "text": "<p><span style=\"font-size:12pt;\">History of amenorrhea</span></p>"
        },
        {
          "id": 23689,
          "text": "<p><span style=\"font-size:12pt;\">Diabetes mellitus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Which of the following is an absolute contraindication to OCP use?</span><span style=\"font-size:12.0pt;\"> (NEET PG 2019)</span></p>",
      "unique_key": "Q4374016",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585477,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Thromboembolism</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Thromboembolism is an absolute contraindication to the use of Oral Contraceptive Pills (OCPs). The use of combined oral contraceptives (COCs) can significantly increase the risk of venous thromboembolism, particularly in individuals with a history of thromboembolic events or known thrombogenic mutations.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Absolute Contraindications of Combined OCPs according to the WHO Medical Eligibility Criteria:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>MEC Category 4:</strong> Unacceptable health risk if the method is used.</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">Breastfeeding and &lt; 6 weeks postpartum</span></li><li><span style=\"font-size:12pt;\">Not breastfeeding; &lt; 21 days postpartum with risk factors for Venous Thromboembolism</span></li><li><span style=\"font-size:12pt;\">Age ≥ 35 years with smoking ≥ 15 cigarettes/day</span></li><li><span style=\"font-size:12pt;\">Hypertension with systolic BP ≥ 160 OR Diastolic BP ≥ 100 mmHg</span></li><li><span style=\"font-size:12pt;\">Hypertension with vascular disease</span></li><li><span style=\"font-size:12pt;\">History of DVT/Pulmonary embolism</span></li><li><span style=\"font-size:12pt;\">Acute DVT/Pulmonary embolism</span></li><li><span style=\"font-size:12pt;\">DVT/Pulmonary embolism on anticoagulant therapy</span></li><li><span style=\"font-size:12pt;\">Major surgery with prolonged immobilization</span></li><li><span style=\"font-size:12pt;\">Known thrombogenic mutations (e.g., Factor V Leiden, prothrombin mutation, protein S, C, antithrombin deficiency)</span></li><li><span style=\"font-size:12pt;\">Current and history of ischemic heart disease</span></li><li><span style=\"font-size:12pt;\">Stroke (history of cerebrovascular disease)</span></li><li><span style=\"font-size:12pt;\">Complicated valvular heart disease</span></li><li><span style=\"font-size:12pt;\">Antiphospholipid Antibody Syndrome</span></li><li><span style=\"font-size:12pt;\">Migraine with aura (any age)</span></li><li><span style=\"font-size:12pt;\">Current breast cancer</span></li><li><span style=\"font-size:12pt;\">Severe cirrhosis</span></li><li><span style=\"font-size:12pt;\">Hepatocellular adenoma/carcinoma</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Chronic Renal Disease</strong>: Chronic renal disease is not an absolute contraindication but requires careful consideration depending on the severity and associated conditions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. History of Amenorrhea</strong>: A history of amenorrhea is not an absolute contraindication to the use of OCPs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Diabetes Mellitus</strong>: Diabetes mellitus is not an absolute contraindication. However, it requires careful monitoring, especially if the patient has vascular complications.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Thromboembolism is an absolute contraindication to the use of combined oral contraceptives (COCs) due to the increased risk of venous thromboembolism associated with these medications.</span></p><p>&nbsp;</p>",
      "correct_choice_id": 23687,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47301,
      "choices": [
        {
          "id": 188815,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">6 &ndash; 10 weeks</span></span></span></span></p>"
        },
        {
          "id": 188816,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">11 &ndash; 14 weeks</span></span></span></span></p>"
        },
        {
          "id": 188817,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">16 &ndash; 20 weeks</span></span></span></span></p>"
        },
        {
          "id": 188818,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">24 &ndash; 28 weeks</span></span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">When is the quadruple marker test done? (FMGE JULY 2023)</span></span></p>",
      "unique_key": "Q9625488",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585490,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. </span></span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C) 16 &ndash; 20 weeks</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The quadruple marker test is a <strong>prenatal screening test</strong> performed during the <strong>second trimester of pregnancy</strong>, typically <strong>between 16 and 20 weeks of gestation</strong>. </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This test is used to assess the risk of certain genetic disorders, including <strong>Down syndrome (trisomy 21)</strong>, trisomy 18, and neural tube defects.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The quadruple marker test measures four specific substances in the mother&#39;s blood:</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Unconjugated estriol (uE3)</span></span></strong></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Free beta-human chorionic gonadotropin (free beta-HCG)</span></span></strong></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inhibin A</span></span></strong></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alpha-fetoprotein (AFP)</span></span></strong></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">These markers provide information about the likelihood of certain fetal abnormalities.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Note -</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> In the case of Down syndrome, free beta-HCG and inhibin A levels tend to be elevated, while unconjugated estriol and alpha-fetoprotein levels are typically decreased.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The quadruple marker test is conducted between 16 and 20 weeks of gestation to screen for genetic disorders such as Down syndrome, trisomy 18, and neural tube defects.</span></span></span></span></p>",
      "correct_choice_id": 188817,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5809,
      "choices": [
        {
          "id": 23206,
          "text": "<p><span style=\"font-size:12pt;\">S3</span></p>"
        },
        {
          "id": 23207,
          "text": "<p><span style=\"font-size:12pt;\">S4</span></p>"
        },
        {
          "id": 23208,
          "text": "<p><span style=\"font-size:12pt;\">Fixed splitting of S2</span></p>"
        },
        {
          "id": 23209,
          "text": "<p><span style=\"font-size:12pt;\">Pericardial knock</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Which of the following heart sounds would be normal in pregnancy?&nbsp;</span>(INICET MAY 2018)</p>",
      "unique_key": "Q2698408",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585483,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) S3</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">During pregnancy, the cardiovascular system undergoes significant changes to accommodate the increased blood volume and cardiac output required to support both the mother and the developing fetus. One of the normal physiological changes includes the presence of the S3 heart sound.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>S3 Heart Sound:</strong> The S3 sound, also known as the ventricular gallop, is due to rapid diastolic filling of the ventricles. It is commonly heard in pregnant women due to the increased blood volume and cardiac output.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other heart sounds mentioned are not typically considered normal in pregnancy</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. S4 Heart Sound:</strong> The S4 sound, or atrial gallop, is generally associated with pathological conditions such as left ventricular hypertrophy or myocardial ischemia. It is rare in pregnancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Fixed Splitting of S2:</strong> Fixed splitting of the second heart sound is usually indicative of an atrial septal defect (ASD) and is not normal in pregnancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Pericardial Knock:</strong> This is a sound heard in cases of constrictive pericarditis and is not a normal finding in pregnancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The S3 heart sound is considered normal during pregnancy due to the increased blood volume and rapid diastolic filling of the ventricles.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 178, Williams Obstetrics 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23206,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20500,
      "choices": [
        {
          "id": 81962,
          "text": "<p><span style=\"font-size:12pt;\">G3P2</span></p>"
        },
        {
          "id": 81963,
          "text": "<p><span style=\"font-size:12pt;\">G3P1</span></p>"
        },
        {
          "id": 81964,
          "text": "<p><span style=\"font-size:12pt;\">G2P1</span></p>"
        },
        {
          "id": 81965,
          "text": "<p><span style=\"font-size:12pt;\">G2P2</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A pregnant woman comes to the clinic. She already has twins by normal delivery. Which of the following is the correct representation of her obstetric score?&nbsp;</span>(NEET PG 2023)</p>",
      "unique_key": "Q8910790",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585469,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) G2P1</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In obstetric history, gravida (G) refers to the number of pregnancies a woman has had, including the current pregnancy, regardless of the outcome or duration. Parity (P) refers to the number of pregnancies that have reached the period of viability (28 weeks in India). Each pregnancy is counted once, regardless of the number of fetuses (e.g., twins count as one pregnancy).</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Gravida (G):</strong> Number of pregnancies, including the current one.</span></li><li><span style=\"font-size:12pt;\"><strong>Parity (P):</strong> Number of pregnancies that have reached viability (28 weeks or more), not including the current pregnancy.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In this case:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The woman has had one previous pregnancy that resulted in the birth of twins.</span></li><li><span style=\"font-size:12pt;\">She is currently pregnant with her second pregnancy.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Therefore, her obstetric score is:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>G2 (Gravida 2):</strong> This is her second pregnancy.</span></li><li><span style=\"font-size:12pt;\"><strong>P1 (Para 1):</strong> She has had one previous pregnancy that reached viability and resulted in the birth of twins.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. G3P2:</strong> This would imply she has had three pregnancies and two that reached viability, which is incorrect.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. G3P1:</strong> This would imply she is in her third pregnancy, which is incorrect.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. G2P2:</strong> This would imply she has had two previous pregnancies that reached viability, which is incorrect.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In obstetric scoring, twin pregnancies count as a single gravida, and the obstetric score for a woman with twins by normal delivery and currently pregnant should be G2P1.</span></p>",
      "correct_choice_id": 81964,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47298,
      "choices": [
        {
          "id": 188803,
          "text": "<p><span style=\"font-size:12.0pt;\">Preeclampsia</span></p>"
        },
        {
          "id": 188804,
          "text": "<p><span style=\"font-size:12.0pt;\">Abruption</span></p>"
        },
        {
          "id": 188805,
          "text": "<p><span style=\"font-size:12.0pt;\">PPH</span></p>"
        },
        {
          "id": 188806,
          "text": "<p><span style=\"font-size:12.0pt;\">Gestational Hypertension</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Patient came to the emergency department with 32 weeks of pregnancy with pedal edema and BP of 140/90 mmHg. Urine dipstick was 2+. What is the likely diagnosis?&nbsp;(FMGE JULY 2023)</span></p>",
      "unique_key": "Q8274686",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585489,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Preeclampsia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient presents with symptoms that align with the diagnosis of preeclampsia, which is characterized by the following criteria:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Elevated blood pressure (≥140/90 mmHg) <strong>after 20 weeks of gestation.</strong></span></li><li><span style=\"font-size:12.0pt;\">Proteinuria (≥1+ on dipstick or 300 mg/24 hours).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In this case, the patient has a blood pressure of 140/90 mmHg and a urine dipstick showing 2+ proteinuria, which fits the criteria for preeclampsia. The presence of pedal edema further supports this diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Abruption</strong>: This typically presents with painful vaginal bleeding and uterine tenderness. While preeclampsia can be a risk factor for abruption, the absence of vaginal bleeding in this case makes abruption less likely.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. PPH (Postpartum Hemorrhage)</strong>: This occurs after delivery and is characterized by significant bleeding post-delivery, which is not relevant in this antepartum scenario.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Gestational Hypertension</strong>: This is characterized by elevated blood pressure without proteinuria or other signs of preeclampsia. The presence of proteinuria in this patient rules out gestational hypertension.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Preeclampsia is diagnosed in pregnant patients presenting with hypertension and proteinuria after 20 weeks of gestation. This condition requires careful monitoring and management to prevent complications for both the mother and the fetus.</span></p>",
      "correct_choice_id": 188803,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6121,
      "choices": [
        {
          "id": 24453,
          "text": "<p><span style=\"font-size:12pt;\">Warning bleeds</span></p>"
        },
        {
          "id": 24454,
          "text": "<p><span style=\"font-size:12pt;\">Dark painful bleeding</span></p>"
        },
        {
          "id": 24455,
          "text": "<p><span style=\"font-size:12pt;\">Uterine tenderness</span></p>"
        },
        {
          "id": 24456,
          "text": "<p><span style=\"font-size:12pt;\">Increased large uterine size</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Which of the following is seen in placenta previa?&nbsp;</span>(INICET NOV 2022)</p>",
      "unique_key": "Q1588915",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585508,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Warning bleeds</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Placenta previa is a condition where the placenta is implanted in the lower uterine segment, either over or close to the internal cervical os. Key features of placenta previa include:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Warning bleeds</strong>: Also known as sentinel bleeds, are sudden-onset, recurrent, painless vaginal bleeding episodes that typically begin in the third trimester or during labor.</span></li><li><span style=\"font-size:12pt;\"><strong>Soft, non-tender uterus</strong>: The abdominal examination reveals a soft and non-tender uterus, with the fundal height proportionate to the gestational age.</span></li><li><span style=\"font-size:12pt;\"><strong>Normal fetal heart rate</strong>: The fetal heart rate is usually normal unless there is severe bleeding due to a large separation.</span></li><li><span style=\"font-size:12pt;\"><strong>Malpresentations are common</strong>: Due to the lower placement of the placenta.</span></li><li><span style=\"font-size:12pt;\"><strong>Diagnosis</strong>: Confirmed via transabdominal sonography or transvaginal sonography, which is safe and more accurate.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Dark painful bleeding</strong>: This is characteristic of placental abruption, not placenta previa. Placental abruption presents with painful, dark vaginal bleeding due to the premature separation of the placenta.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Uterine tenderness</strong>: Uterine tenderness is also a feature of placental abruption, where the uterus becomes firm and tender due to bleeding and clot formation behind the placenta.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Increased large uterine size</strong>: This is not a specific feature of placenta previa. Uterine size in placenta previa is proportionate to the gestational age.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Placenta previa typically presents with painless, recurrent vaginal bleeding (warning bleeds) in the third trimester or during labor, with a soft, non-tender uterus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: William’s textbook of obstetrics 26<sup>th</sup> edition pg1940, Dutta’s textbook of obstetrics 8<sup>th</sup> edition pg 307</strong></span></p>",
      "correct_choice_id": 24453,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6125,
      "choices": [
        {
          "id": 24469,
          "text": "<p><span style=\"font-size:12pt;\">Conservative management</span></p>"
        },
        {
          "id": 24470,
          "text": "<p><span style=\"font-size:12pt;\">Administer tocolytics and deliver at 37 wks</span></p>"
        },
        {
          "id": 24471,
          "text": "<p><span style=\"font-size:12pt;\">Give steroid cover and wait until steroid cover is complete.</span></p>"
        },
        {
          "id": 24472,
          "text": "<p><span style=\"font-size:12pt;\">Treat hypertension, administer MgSO4, and consider termination of pregnancy.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A pregnant woman with 35 weeks+5 days gestation complains of epigastric pain, headache, and blurring of vision. Her blood pressure is 170/110 mmHg. She is in labor pain. Examination of the cervix shows a 3 cm dilatation with a bag of liquor. What is the appropriate management?&nbsp;</span>(INICET NOV 2022)</p>",
      "unique_key": "Q7974292",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585512,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Treat hypertension, administer MgSO4, and consider termination of pregnancy.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">This pregnant woman is presenting with symptoms and signs of severe pre-eclampsia, which include:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Epigastric pain</strong></span></li><li><span style=\"font-size:12pt;\"><strong>Headache</strong></span></li><li><span style=\"font-size:12pt;\"><strong>Blurring of vision</strong></span></li><li><span style=\"font-size:12pt;\"><strong>Severe hypertension</strong>: Blood pressure of 170/110 mmHg.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In the context of severe pre-eclampsia at 35 weeks+5 days gestation, the management should include:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Treating hypertension</strong>: Immediate blood pressure control is crucial to prevent complications such as eclampsia, stroke, or placental abruption.</span></li><li><span style=\"font-size:12pt;\"><strong>Administering magnesium sulfate (MgSO4)</strong>: This is done to prevent eclamptic seizures.</span></li><li><span style=\"font-size:12pt;\"><strong>Consideration for termination of pregnancy</strong>: In cases of severe pre-eclampsia at or beyond 34 weeks, the recommended course of action is to expedite delivery to prevent further maternal and fetal complications.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Conservative management</strong>: Conservative management is not appropriate for severe pre-eclampsia due to the high risk of complications for both the mother and the fetus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Administer tocolytics and deliver at 37 weeks</strong>: Tocolytics are contraindicated in severe pre-eclampsia as the goal is to deliver the baby as soon as the condition is stable, rather than delaying delivery.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Give steroid cover and wait until steroid cover is complete</strong>: As the patient is already beyond 34 weeks of gestation, steroid administration for fetal lung maturity is not necessary, and immediate delivery is preferred.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In cases of severe pre-eclampsia at or beyond 34 weeks of gestation, immediate management involves controlling hypertension, administering magnesium sulfate to prevent seizures, and expediting delivery.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/02/untitled-291.jpg\" alt=\"\" width=\"500\" height=\"593\"></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Williams textbook of obstetrics 26<sup>th</sup> edition pg 1850, &nbsp;Dutta’s textbook of obstetrics 8<sup>th</sup> edition pg267</strong></span></p>",
      "correct_choice_id": 24472,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6110,
      "choices": [
        {
          "id": 24409,
          "text": "<p><span style=\"font-size:12pt;\">Turner syndrome</span></p>"
        },
        {
          "id": 24410,
          "text": "<p><span style=\"font-size:12pt;\">Kallmann syndrome</span></p>"
        },
        {
          "id": 24411,
          "text": "<p><span style=\"font-size:12pt;\">Androgen insensitivity syndrome</span></p>"
        },
        {
          "id": 24412,
          "text": "<p><span style=\"font-size:12pt;\">Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 16-year-old presents with absent menses. Examination shows widely spaced nipples, webbed neck, and Tanner grade 1 breast development. USG shows streak ovaries. Investigation shows raised FSH, raised LH, and reduced estradiol. What is the diagnosis?&nbsp;</span>(INICET NOV 2022)</p>",
      "unique_key": "Q6425081",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585507,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Turner syndrome</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The patient's clinical features are strongly suggestive of Turner syndrome (45XO), a condition characterized by:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Widely spaced nipples</strong>: Shield chest appearance.</span></li><li><span style=\"font-size:12pt;\"><strong>Webbed neck</strong>: Due to congenital lymphedema.</span></li><li><span style=\"font-size:12pt;\"><strong>Tanner grade 1 breast development</strong>: Indicates no breast development.</span></li><li><span style=\"font-size:12pt;\"><strong>Streak ovaries</strong> on ultrasound: Ovaries that are underdeveloped and nonfunctional.</span></li><li><span style=\"font-size:12pt;\"><strong>Hormonal profile</strong>: Raised FSH and LH due to lack of negative feedback from the ovaries, and reduced estradiol indicating ovarian failure.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Other clinical features of Turner syndrome include short stature, primary amenorrhea, congenital heart defects, and renal anomalies. The syndrome results in hypergonadotropic hypogonadism.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Kallmann syndrome</strong>: It is characterized by hypogonadotropic hypogonadism and anosmia (lack of sense of smell), not hypergonadotropic hypogonadism.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Androgen insensitivity syndrome</strong>: 46XY karyotype with female external genitalia, well-developed breasts, absent axillary and pubic hair, and gonads are testes, not streak ovaries.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Mayer-Rokitansky-Küster-Hauser syndrome</strong>: Mullerian agenesis, where secondary sexual characters are present but the uterus, fallopian tubes, and upper vagina are absent. This syndrome does not present with webbed neck or widely spaced nipples.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Turner syndrome is characterized by primary amenorrhea, streak ovaries, hypergonadotropic hypogonadism, widely spaced nipples, and a webbed neck.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: William’s textbook of Gynecology 3<sup>rd</sup> edition pg411, Dutta’s textbook of gynecology 6<sup>th</sup> edition pg 441</strong></span></p>",
      "correct_choice_id": 24409,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}